data_1k81_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1k81 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 tttt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.809 0.337 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.39 136.76 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.67 -95.85 0.06 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.816 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 35.58 1.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.083 0.468 . . . . 0.0 111.695 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.92 136.85 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -109.59 137.47 47.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.654 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.1 tp -129.51 137.23 50.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.62 136.41 52.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.432 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -130.19 137.69 50.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.129 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 51.0 t -119.84 135.98 54.66 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.28 130.74 55.49 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.785 0.803 . . . . 0.0 110.134 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 133.57 -38.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.207 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 23.9 p -114.08 -11.44 12.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.911 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.22 66.93 2.44 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.712 -178.709 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.943 0.401 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.43 137.12 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.91 -112.92 4.81 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.939 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -126.27 27.23 6.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.28 136.67 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.56 137.76 46.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.64 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mt -128.07 137.36 52.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 tt -109.82 136.57 48.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.034 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -129.49 137.82 51.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.424 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.1 t -119.44 136.23 54.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.564 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.9 mmm -108.68 131.1 55.24 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.905 0.859 . . . . 0.0 110.835 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 131.12 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.964 -1.925 . . . . 0.0 108.458 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 p -110.56 -12.71 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.729 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.32 67.69 2.03 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.682 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.546 -179.011 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.923 0.392 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.47 136.82 49.38 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.01 -104.85 0.51 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.945 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.32 32.97 3.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.671 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.21 136.91 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -109.72 137.88 46.89 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.685 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mp -128.21 137.08 51.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.14 136.54 52.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.683 0.754 . . . . 0.0 109.798 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.642 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 49.7 t -122.13 135.63 54.82 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.6 ttm -109.61 130.7 55.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.957 0.884 . . . . 0.0 111.026 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.34 -38.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.742 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.81 -9.33 14.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.897 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.85 65.58 3.43 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.73 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.49 -178.864 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.995 0.426 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.44 137.04 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.41 -106.0 0.76 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.991 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.69 27.94 3.96 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 111.909 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.19 136.7 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -109.69 138.01 46.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.755 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.17 137.08 52.87 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.8 mt -117.85 136.91 53.13 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.904 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -128.93 137.17 51.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.676 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 40.8 t -123.48 136.28 54.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.1 mtm -109.31 130.72 55.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.889 0.852 . . . . 0.0 110.034 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.37 -42.31 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.01 -1.905 . . . . 0.0 107.831 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.9 p -108.86 -11.99 14.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.141 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.22 65.17 3.7 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.678 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.745 -178.818 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.916 0.389 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.53 137.04 49.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.57 7.25 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.006 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.81 26.93 7.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.936 0.398 . . . . 0.0 111.753 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 t -132.19 136.54 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -109.65 137.69 47.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.782 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.44 137.31 51.78 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tt -111.6 136.49 50.74 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.267 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -129.89 137.69 50.53 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.257 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 54.1 t -119.62 135.95 54.59 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.58 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 37.8 mtt -109.11 130.89 55.49 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.856 0.836 . . . . 0.0 110.617 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 127.48 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.998 -1.91 . . . . 0.0 108.273 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -15.05 14.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.349 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.36 67.24 2.27 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.761 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.343 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.62 -178.995 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.94 0.4 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -130.47 136.8 49.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.55 -100.09 0.12 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.938 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.67 34.14 1.81 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.728 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.53 137.11 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -109.38 137.45 47.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.472 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.48 137.46 50.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.96 136.46 52.61 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.027 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.15 137.69 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.488 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 46.2 t -118.56 136.59 53.77 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 1.0 OUTLIER -108.93 130.48 55.45 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.707 0.765 . . . . 0.0 109.692 178.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.54 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.991 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.2 p -115.35 -12.12 11.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.93 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.1 67.52 2.11 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.549 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.611 -178.872 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.956 0.408 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -130.34 137.2 49.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.51 -120.27 21.4 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.07 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.28 22.67 12.33 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.875 0.369 . . . . 0.0 111.856 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.15 136.32 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -109.76 137.4 47.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.942 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.68 137.25 50.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.0 mp -117.33 135.87 53.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.614 0.721 . . . . 0.0 109.832 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.52 137.56 49.79 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.457 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 t -127.36 135.87 51.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.566 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -109.24 131.01 55.48 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 178.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.49 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.226 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 31.0 p -107.29 -10.59 15.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.408 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.36 65.57 3.47 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.725 -178.754 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.898 0.38 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -130.4 137.26 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.592 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.67 -119.35 17.88 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.092 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 20.39 13.42 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.99 136.37 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -109.89 137.67 47.35 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.827 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.7 137.29 51.53 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.77 136.23 49.42 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.381 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -130.19 137.75 50.24 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.919 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 3.2 t -121.9 135.32 54.88 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.578 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.84 131.17 55.3 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.476 0.655 . . . . 0.0 110.584 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 126.34 -38.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.424 -1.716 . . . . 0.0 108.466 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.9 p -107.73 -14.02 14.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.776 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.97 67.62 2.07 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.7 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.253 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.552 -178.744 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -130.31 136.84 49.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.77 -100.25 0.19 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.839 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.28 31.94 1.92 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.826 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.06 136.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.68 137.69 47.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.736 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.85 137.33 51.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.7 tt -114.79 136.17 53.38 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.533 0.682 . . . . 0.0 109.696 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -130.47 137.71 49.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.362 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 t -122.68 136.28 54.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.558 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -108.82 131.2 55.21 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.899 0.856 . . . . 0.0 110.522 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.93 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.448 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.4 p -109.43 -10.26 14.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.704 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.16 65.64 3.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.765 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.232 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.498 -179.048 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.8 mttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.848 0.356 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.65 137.24 49.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.34 -113.46 4.87 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.225 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mmt-85 -124.09 21.37 8.93 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.89 136.58 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -109.59 137.58 47.21 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.786 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.8 mt -129.29 137.31 50.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.65 136.14 53.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.265 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -130.26 137.81 50.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.275 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.0 t -122.97 136.32 54.81 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' MET . . . . . 0.553 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.4 mpp? -108.2 131.51 54.6 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.169 0.985 . . . . 0.0 111.099 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 121.39 -44.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 112.248 -2.251 . . . . 0.0 108.377 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -15.2 22.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.964 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.49 66.43 2.84 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.942 -178.667 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.757 0.313 . . . . 0.0 111.453 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 8.9 mt -65.43 -49.5 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 121.94 0.876 . . . . 0.0 111.312 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.468 ' HB3' ' HB2' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -131.27 99.5 4.87 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.783 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -33.76 15.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.262 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -96.54 34.41 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.468 ' HB2' ' HB3' ' A' ' 110' ' ' CYS . 0.5 OUTLIER -116.42 -29.34 6.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.016 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.6 -114.92 4.13 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.628 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.08 81.33 20.11 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 110.527 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.424 ' HB3' ' CB ' ' A' ' 133' ' ' ALA . 76.8 Cg_endo -101.15 -148.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 123.969 3.113 . . . . 0.0 111.704 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.36 152.6 50.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.2 t -126.71 132.18 51.2 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.407 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -132.78 137.38 46.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.721 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.5 tt -128.54 136.22 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.0 110.574 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.22 136.86 57.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.36 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -128.3 136.47 51.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.337 . . . . 0.0 110.484 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.39 136.76 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.67 -95.85 0.06 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.816 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 35.58 1.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.083 0.468 . . . . 0.0 111.695 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.92 136.85 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -109.59 137.47 47.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.654 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.1 tp -129.51 137.23 50.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.62 136.41 52.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.432 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -130.19 137.69 50.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.129 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 51.0 t -119.84 135.98 54.66 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.28 130.74 55.49 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.785 0.803 . . . . 0.0 110.134 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 133.57 -38.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.207 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 23.9 p -114.08 -11.44 12.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.911 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.22 66.93 2.44 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.33 137.4 54.85 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.712 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 4.0 mp -123.23 135.9 61.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.06 0.457 . . . . 0.0 110.641 177.136 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.33 137.06 30.0 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 178.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.7 Cg_endo -93.75 134.81 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.396 2.731 . . . . 0.0 112.221 177.824 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.4 HG22 HD12 ' A' ' 140' ' ' ILE . 28.4 mt -144.27 156.81 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 28.6 ptt85 -165.8 126.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.41 -36.85 5.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 1 C--O 1.092 -7.206 1 CA-C-O 89.086 -14.769 . . . . 0.0 111.079 -179.93 . . . . . . . . 2 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.621 0.248 . . . . 0.0 111.631 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.3 tt -61.37 -49.35 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.862 0.839 . . . . 0.0 111.522 -179.631 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.709 ' HB3' ' HB2' ' A' ' 113' ' ' CYS . 8.1 m -159.69 119.12 2.9 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.522 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -95.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.175 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.7 43.39 1.13 Allowed 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.093 0.473 . . . . 0.0 111.035 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.709 ' HB2' ' HB3' ' A' ' 110' ' ' CYS . 0.5 OUTLIER -76.73 71.71 3.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.152 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.91 117.31 4.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.407 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.434 ' N ' ' HD3' ' A' ' 116' ' ' PRO . 6.1 tttp 52.59 63.76 8.34 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.784 0.326 . . . . 0.0 110.73 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.479 ' HB3' ' CB ' ' A' ' 133' ' ' ALA . 85.6 Cg_endo -101.85 -151.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.834 3.023 . . . . 0.0 111.811 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.29 160.15 42.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.216 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.0 p -124.18 132.15 53.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.115 0.484 . . . . 0.0 111.323 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.62 137.56 47.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.729 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.01 136.15 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.931 0.396 . . . . 0.0 110.781 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.41 137.19 56.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.199 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.54 136.41 51.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 110.605 177.585 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.43 137.12 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.91 -112.92 4.81 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.939 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -126.27 27.23 6.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.28 136.67 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.56 137.76 46.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.64 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mt -128.07 137.36 52.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 tt -109.82 136.57 48.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.034 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -129.49 137.82 51.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.424 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.1 t -119.44 136.23 54.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.564 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.9 mmm -108.68 131.1 55.24 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.905 0.859 . . . . 0.0 110.835 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 131.12 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.964 -1.925 . . . . 0.0 108.458 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 p -110.56 -12.71 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.729 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.32 67.69 2.03 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.682 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -122.98 137.28 55.0 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.546 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.5 pt -127.95 136.01 61.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 110.654 177.364 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -130.34 137.04 29.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.42 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -94.35 135.34 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.375 2.716 . . . . 0.0 112.338 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.3 pt -147.57 149.53 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.904 0.383 . . . . 0.0 111.173 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.94 97.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.997 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.4 mtp -106.66 -174.02 2.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.837 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.4 tt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.086 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.617 0.246 . . . . 0.0 111.486 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.5 mt -49.94 -49.54 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.944 0.878 . . . . 0.0 111.418 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.33 38.34 1.27 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.666 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.71 -30.56 13.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.832 179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -96.17 29.02 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.784 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.92 109.35 20.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.06 61.82 4.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.222 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 mttt 45.09 60.85 12.71 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-O 120.765 0.317 . . . . 0.0 111.583 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.488 ' HG3' ' HB3' ' A' ' 133' ' ' ALA . 96.6 Cg_endo -80.77 -102.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.64 2.226 . . . . 0.0 112.13 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.04 146.09 51.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.533 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m -128.82 131.7 47.76 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.071 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 137.21 44.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.11 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.39 136.18 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.32 136.96 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.794 0.33 . . . . 0.0 110.393 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -128.97 136.48 50.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.675 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.47 136.82 49.38 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.01 -104.85 0.51 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.945 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.32 32.97 3.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.671 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.21 136.91 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -109.72 137.88 46.89 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.685 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 8.6 mp -128.21 137.08 51.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.314 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.14 136.54 52.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.683 0.754 . . . . 0.0 109.798 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.642 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 49.7 t -122.13 135.63 54.82 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.6 ttm -109.61 130.7 55.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.957 0.884 . . . . 0.0 111.026 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.34 -38.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.742 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.81 -9.33 14.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.897 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.85 65.58 3.43 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.73 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.41 137.41 54.33 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.49 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.1 pp -126.19 136.15 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 110.486 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -130.19 136.52 29.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.563 178.25 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.1 Cg_endo -97.02 114.27 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.685 2.923 . . . . 0.0 112.365 178.091 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 26.3 mm -117.85 88.47 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.883 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -100.86 -26.21 13.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.051 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 9.1 mtt 62.43 -175.66 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.751 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 1 C--O 0.474 -39.726 1 CA-C-O 52.349 -32.262 . . . . 0.0 111.085 179.962 . . . . . . . . 2 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.749 0.309 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.2 mt -58.85 -49.41 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 121.925 0.869 . . . . 0.0 111.288 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.4 m -100.57 82.2 2.42 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -117.89 26.52 9.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.48 -44.69 2.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.89 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 134' ' ' CYS . 1.0 OUTLIER -60.08 -56.71 18.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.78 179.972 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.15 123.15 0.01 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.833 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.576 ' N ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 41.11 55.46 8.07 Favored Pre-proline 0 N--CA 1.465 0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 111.514 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.576 ' HD3' ' N ' ' A' ' 115' ' ' LYS . 87.8 Cg_endo -103.42 -150.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 123.816 3.011 . . . . 0.0 111.751 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.81 146.23 43.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.6 p -127.85 132.08 49.42 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.578 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.18 137.47 46.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.517 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 35.9 mt -128.89 136.34 60.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.959 0.409 . . . . 0.0 111.002 178.109 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.2 mm -130.09 137.06 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.992 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.89 136.21 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.995 0.426 . . . . 0.0 110.712 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.44 137.04 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.41 -106.0 0.76 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.991 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.69 27.94 3.96 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 111.909 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.19 136.7 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.408 ' CD2' ' HG3' ' A' ' 141' ' ' ARG . 7.7 m-70 -109.69 138.01 46.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.755 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.17 137.08 52.87 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.8 mt -117.85 136.91 53.13 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.904 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -128.93 137.17 51.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.676 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 40.8 t -123.48 136.28 54.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.1 mtm -109.31 130.72 55.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.889 0.852 . . . . 0.0 110.034 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.37 -42.31 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.01 -1.905 . . . . 0.0 107.831 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 113' ' ' CYS . 20.9 p -108.86 -11.99 14.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.141 177.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.22 65.17 3.7 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.678 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -130.21 137.21 49.94 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.745 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.0 tt -127.4 135.96 61.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.896 0.379 . . . . 0.0 110.382 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 1.8 ptt180 -130.36 137.08 30.04 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.736 178.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -95.14 145.87 1.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.488 2.792 . . . . 0.0 111.986 177.676 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.0 pt -150.27 147.39 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.962 0.41 . . . . 0.0 111.156 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . 0.408 ' HG3' ' CD2' ' A' ' 127' ' ' HIS . 1.4 mmp_? 62.46 67.5 0.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.904 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 2.9 ptp -118.57 94.09 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 1.434 ' OXT' ' CA ' ' A' ' 143' ' ' ILE . 3.9 mp . . . . . 1 C--O 0.272 -50.367 1 CA-C-O 89.583 -14.532 . . . . 0.0 111.099 -179.941 . . . . . . . . 3 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.433 HG23 HD12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -53.01 -48.91 51.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 121.729 0.776 . . . . 0.0 111.603 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -172.43 142.93 1.34 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.539 179.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -46.66 -60.93 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.325 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.65 68.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.061 0.457 . . . . 0.0 110.412 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 118.42 18.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.369 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.63 -56.35 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.909 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.551 ' N ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -156.77 55.86 1.09 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.73 0.3 . . . . 0.0 110.611 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.551 ' HD3' ' N ' ' A' ' 115' ' ' LYS . 44.4 Cg_endo -97.82 -141.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.408 2.738 . . . . 0.0 111.739 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 2.5 m-20 -121.91 153.16 38.81 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.382 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.6 p -126.56 132.15 51.38 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.377 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.3 tttp -133.03 137.54 46.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.801 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.4 mt -127.85 136.09 61.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.934 0.397 . . . . 0.0 110.673 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.29 137.4 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.257 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 136.34 51.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.463 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.53 137.04 49.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.57 7.25 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.006 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.81 26.93 7.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.936 0.398 . . . . 0.0 111.753 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 t -132.19 136.54 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . 0.4 ' HB2' HG13 ' A' ' 140' ' ' ILE . 7.4 m-70 -109.65 137.69 47.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.782 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.44 137.31 51.78 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tt -111.6 136.49 50.74 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.267 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -129.89 137.69 50.53 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.257 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 54.1 t -119.62 135.95 54.59 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.58 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 37.8 mtt -109.11 130.89 55.49 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.856 0.836 . . . . 0.0 110.617 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 127.48 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.998 -1.91 . . . . 0.0 108.273 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -15.05 14.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.349 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.36 67.24 2.27 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.761 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.46 137.26 52.64 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.62 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.3 pp -127.69 135.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.007 0.432 . . . . 0.0 110.803 177.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 50.5 mtp180 -130.31 136.93 29.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.411 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -95.76 137.51 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.438 2.759 . . . . 0.0 112.227 177.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . 0.405 HD11 HG22 ' A' ' 140' ' ' ILE . 30.4 pt -150.57 140.71 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 111.274 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -152.97 43.17 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.2 108.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 21.6 pt . . . . . 1 C--O 0.899 -17.345 1 CA-C-O 14.687 -50.197 . . . . 0.0 111.136 -179.995 . . . . . . . . 2 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.411 HG11 ' CD1' ' A' ' 109' ' ' ILE . 2.7 t . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.582 0.229 . . . . 0.0 111.581 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.411 ' CD1' HG11 ' A' ' 108' ' ' VAL . 12.4 mm -55.77 -70.22 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 122.234 1.016 . . . . 0.0 111.635 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.602 ' HB3' ' HB2' ' A' ' 113' ' ' CYS . 0.0 OUTLIER -168.43 135.93 2.08 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.846 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.13 -23.66 16.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.816 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -128.94 55.05 1.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.058 0.456 . . . . 0.0 111.063 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.602 ' HB2' ' HB3' ' A' ' 110' ' ' CYS . 0.5 OUTLIER -123.68 -53.22 1.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.924 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.43 61.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.533 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.92 76.28 0.54 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.955 0.407 . . . . 0.0 110.819 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.44 ' HB2' ' H ' ' A' ' 117' ' ' ASP . 47.5 Cg_endo -99.77 -145.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.739 2.959 . . . . 0.0 111.484 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.44 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 2.0 m-20 -129.43 152.04 49.4 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.056 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.55 132.01 54.96 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.528 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -133.25 137.5 46.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.397 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 12.1 tt -127.92 136.03 61.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.973 0.416 . . . . 0.0 110.874 177.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 tp -130.35 137.32 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.9 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.62 136.38 51.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.94 0.4 . . . . 0.0 110.724 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 31.8 mt-10 -130.47 136.8 49.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.55 -100.09 0.12 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.938 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.67 34.14 1.81 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.728 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.53 137.11 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -109.38 137.45 47.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.472 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.48 137.46 50.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.96 136.46 52.61 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.027 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.15 137.69 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.488 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 46.2 t -118.56 136.59 53.77 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 1.0 OUTLIER -108.93 130.48 55.45 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.707 0.765 . . . . 0.0 109.692 178.424 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.54 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.991 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.2 p -115.35 -12.12 11.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.93 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.1 67.52 2.11 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.549 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.64 137.51 54.72 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.611 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.7 pp -127.1 135.86 62.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.063 0.458 . . . . 0.0 110.721 177.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.1 mtt-85 -130.36 137.19 30.29 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.484 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -92.4 139.45 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.251 2.634 . . . . 0.0 112.233 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 2.2 tt -157.63 137.56 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.182 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 146.72 49.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 63.9 mtp 60.05 178.67 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.5 tt . . . . . 0 C--O 1.189 -2.092 1 CA-C-O 61.938 -27.696 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.764 0.316 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 9.2 mt -68.11 -70.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 121.919 0.866 . . . . 0.0 111.466 -179.767 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.45 ' CB ' ' HB2' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -114.57 128.53 56.38 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.894 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.61 83.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.398 . . . . 0.0 109.998 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 66.59 61.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.162 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.45 ' HB2' ' CB ' ' A' ' 110' ' ' CYS . 12.1 t -55.0 -78.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.594 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.78 -66.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.817 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.405 ' CB ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -169.46 -61.76 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.656 0.228 . . . . 0.0 111.555 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HB2' ' O ' ' A' ' 132' ' ' MET . 37.8 Cg_exo -36.66 -99.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.142 2.561 . . . . 0.0 113.419 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.436 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 0.1 OUTLIER 171.48 -171.0 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.348 0.522 . . . . 0.0 111.71 -179.87 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.2 t -130.05 133.63 46.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.797 -179.696 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -128.75 137.31 51.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 2.4 mt -115.2 136.63 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.588 177.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.7 tp -129.93 137.46 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 110.249 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.48 136.52 51.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -130.34 137.2 49.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.51 -120.27 21.4 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.07 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.28 22.67 12.33 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.875 0.369 . . . . 0.0 111.856 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.15 136.32 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -109.76 137.4 47.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.942 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -129.68 137.25 50.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 11.0 mp -117.33 135.87 53.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.614 0.721 . . . . 0.0 109.832 177.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.52 137.56 49.79 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.457 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 t -127.36 135.87 51.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.566 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -109.24 131.01 55.48 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 178.581 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.49 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.226 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 31.0 p -107.29 -10.59 15.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.408 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.36 65.57 3.47 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -126.52 137.28 53.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.725 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 pt -127.74 135.86 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.411 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.29 136.78 29.53 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.69 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -96.68 133.01 0.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.579 2.853 . . . . 0.0 112.165 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.2 mp -136.13 133.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.82 0.343 . . . . 0.0 111.078 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 65.35 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -100.56 171.39 7.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 1 C--O 1.145 -4.418 1 CA-C-O 77.1 -20.476 . . . . 0.0 111.081 -179.931 . . . . . . . . 2 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.6 t . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.748 0.309 . . . . 0.0 111.638 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.9 tp -49.94 -48.6 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.723 0.773 . . . . 0.0 111.768 -179.545 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.417 ' CB ' ' HB2' ' A' ' 113' ' ' CYS . 0.0 OUTLIER 77.26 -66.09 0.25 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.401 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 165.06 -64.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.866 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.06 29.1 3.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.852 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.417 ' HB2' ' CB ' ' A' ' 110' ' ' CYS . 0.0 OUTLIER -89.38 125.78 35.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.641 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.02 34.22 0.08 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.539 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.577 ' CB ' ' HD3' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -177.99 -67.6 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 117.144 0.472 . . . . 0.0 111.775 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.577 ' HD3' ' CB ' ' A' ' 115' ' ' LYS . 84.2 Cg_exo -47.48 -104.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.252 1.968 . . . . 0.0 112.807 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . 0.466 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER 168.52 -166.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.332 0.515 . . . . 0.0 110.822 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 18.9 p -129.29 132.73 47.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.815 0.34 . . . . 0.0 110.684 179.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -131.3 137.45 48.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.649 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 pp -114.06 136.51 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.154 177.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.413 ' CG2' HD13 ' A' ' 128' ' ' LEU . 0.5 OUTLIER -130.16 137.46 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.571 178.498 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.82 136.34 52.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -130.4 137.26 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.592 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.67 -119.35 17.88 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.092 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 20.39 13.42 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.99 136.37 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -109.89 137.67 47.35 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.827 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . 0.413 HD13 ' CG2' ' A' ' 121' ' ' ILE . 0.9 OUTLIER -128.7 137.29 51.53 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.407 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.77 136.23 49.42 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.381 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -130.19 137.75 50.24 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.919 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 3.2 t -121.9 135.32 54.88 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.578 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.84 131.17 55.3 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.476 0.655 . . . . 0.0 110.584 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 126.34 -38.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.424 -1.716 . . . . 0.0 108.466 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.9 p -107.73 -14.02 14.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.776 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.97 67.62 2.07 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.7 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.53 137.51 54.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.552 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mt -126.53 135.83 62.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . 0.409 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.35 136.81 29.57 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.413 178.403 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HD3' ' HA ' ' A' ' 138' ' ' ARG . 59.9 Cg_endo -94.97 126.99 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.476 2.784 . . . . 0.0 112.467 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.5 mt -131.15 136.74 57.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.855 0.36 . . . . 0.0 110.966 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 5.0 mtt180 61.21 113.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.93 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.26 34.56 1.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.418 ' OXT' HG13 ' A' ' 143' ' ' ILE . 14.4 pt . . . . . 1 C--O 0.987 -12.723 1 CA-C-O 87.661 -15.447 . . . . 0.0 111.173 179.992 . . . . . . . . 3 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 2.4 pp -52.45 -49.07 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.828 0.823 . . . . 0.0 111.906 -179.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . 0.602 ' CB ' ' HB2' ' A' ' 113' ' ' CYS . 1.2 m -172.36 -170.0 0.67 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.557 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -82.07 -69.53 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.542 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -125.02 46.61 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.374 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . 0.602 ' HB2' ' CB ' ' A' ' 110' ' ' CYS . 0.1 OUTLIER -99.57 76.29 2.0 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.812 -179.435 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -47.89 -85.94 0.01 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.9 -179.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -118.09 82.09 17.3 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.809 0.338 . . . . 0.0 110.213 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.495 ' HB3' ' CB ' ' A' ' 133' ' ' ALA . 39.0 Cg_endo -104.4 -150.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 124.004 3.136 . . . . 0.0 112.077 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.79 155.91 41.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.832 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 p -125.24 132.02 53.03 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.402 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -133.1 137.48 46.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.594 179.237 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 23.7 mm -128.85 136.17 60.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.825 0.345 . . . . 0.0 110.633 177.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.27 137.18 56.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.286 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.26 136.51 51.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.661 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -130.31 136.84 49.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.77 -100.25 0.19 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.839 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.28 31.94 1.92 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.826 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.06 136.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.68 137.69 47.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.736 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -128.85 137.33 51.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.497 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.7 tt -114.79 136.17 53.38 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.533 0.682 . . . . 0.0 109.696 178.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -130.47 137.71 49.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.362 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 t -122.68 136.28 54.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.558 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -108.82 131.2 55.21 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.899 0.856 . . . . 0.0 110.522 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.93 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.448 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.4 p -109.43 -10.26 14.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.704 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.16 65.64 3.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.765 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -119.67 137.1 54.11 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.498 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.8 pt -128.65 136.23 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.399 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 8.1 mtt180 -130.17 136.44 29.02 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 178.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -98.38 132.0 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.825 3.017 . . . . 0.0 112.438 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mp -133.47 92.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.879 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -72.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.046 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.4 ptm -71.26 164.02 26.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.499 HG22 HD13 ' A' ' 143' ' ' ILE . 0.0 OUTLIER . . . . . 1 C--O 0.902 -17.212 1 CA-C-O 55.734 -30.651 . . . . 0.0 111.028 179.949 . . . . . . . . 4 3 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.403 HG12 ' HB2' ' A' ' 111' ' ' ARG . 2.2 tt -53.54 -49.53 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.794 0.807 . . . . 0.0 112.051 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 46.8 t 51.32 24.94 2.3 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.532 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ARG . . . . . 0.403 ' HB2' HG12 ' A' ' 109' ' ' ILE . 0.0 OUTLIER -103.5 -56.56 2.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.869 0.366 . . . . 0.0 110.51 179.529 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.6 8.78 35.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.042 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 2.1 p -55.71 91.8 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.54 -24.39 21.32 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.453 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.59 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -55.97 -37.9 62.23 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 115' ' ' LYS . 46.9 Cg_endo -92.86 -138.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.941 2.427 . . . . 0.0 111.611 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.62 150.52 45.08 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.222 179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.69 131.98 48.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 110.761 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -133.22 137.75 46.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.224 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.28 136.0 58.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.388 . . . . 0.0 110.345 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.495 HD12 HG21 ' A' ' 121' ' ' ILE . 30.1 mm -130.44 137.38 56.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.446 178.316 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -126.43 136.22 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.624 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.65 137.24 49.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.34 -113.46 4.87 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.225 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mmt-85 -124.09 21.37 8.93 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.89 136.58 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -109.59 137.58 47.21 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.786 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.8 mt -129.29 137.31 50.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.65 136.14 53.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.265 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -130.26 137.81 50.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.275 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.0 t -122.97 136.32 54.81 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' MET . . . . . 0.553 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.4 mpp? -108.2 131.51 54.6 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.169 0.985 . . . . 0.0 111.099 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 121.39 -44.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 112.248 -2.251 . . . . 0.0 108.377 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -15.2 22.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.964 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.49 66.43 2.84 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.2 137.28 52.88 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.942 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.13 135.88 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.076 177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.29 137.01 29.89 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.719 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -94.98 134.68 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.547 2.831 . . . . 0.0 112.231 177.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 27.2 mm -138.54 120.7 17.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 111.106 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.57 107.36 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.811 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' MET . . . . . 0.851 ' O ' ' O ' ' A' ' 143' ' ' ILE . 0.5 OUTLIER 61.49 162.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ILE . . . . . 0.851 ' O ' ' O ' ' A' ' 142' ' ' MET . 2.1 pp . . . . . 1 C--O 1.117 -5.913 1 CA-C-O 62.672 -27.347 . . . . 0.0 111.128 -179.939 . . . . . . . . 3 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 tttt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.809 0.337 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.39 136.76 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.67 -95.85 0.06 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.816 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 35.58 1.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.083 0.468 . . . . 0.0 111.695 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.92 136.85 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -109.59 137.47 47.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.654 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.1 tp -129.51 137.23 50.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.62 136.41 52.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.432 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -130.19 137.69 50.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.129 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 51.0 t -119.84 135.98 54.66 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.28 130.74 55.49 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.785 0.803 . . . . 0.0 110.134 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 133.57 -38.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.207 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 23.9 p -114.08 -11.44 12.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.911 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.22 66.93 2.44 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.712 -178.709 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.943 0.401 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.43 137.12 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.91 -112.92 4.81 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.939 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -126.27 27.23 6.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.28 136.67 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.56 137.76 46.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.64 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mt -128.07 137.36 52.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 tt -109.82 136.57 48.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.034 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -129.49 137.82 51.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.424 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.1 t -119.44 136.23 54.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.564 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.9 mmm -108.68 131.1 55.24 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.905 0.859 . . . . 0.0 110.835 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 131.12 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.964 -1.925 . . . . 0.0 108.458 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 p -110.56 -12.71 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.729 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.32 67.69 2.03 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.682 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.546 -179.011 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.923 0.392 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.47 136.82 49.38 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.01 -104.85 0.51 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.945 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.32 32.97 3.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.671 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.21 136.91 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' HIS . . . . . 0.409 ' C ' HD12 ' A' ' 128' ' ' LEU . 8.0 m-70 -109.72 137.88 46.89 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.685 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 127' ' ' HIS . 8.6 mp -128.21 137.08 51.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.14 136.54 52.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.683 0.754 . . . . 0.0 109.798 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.642 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 49.7 t -122.13 135.63 54.82 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.6 ttm -109.61 130.7 55.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.957 0.884 . . . . 0.0 111.026 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.34 -38.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.742 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.81 -9.33 14.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.897 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.85 65.58 3.43 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.73 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.49 -178.864 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.995 0.426 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.44 137.04 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.41 -106.0 0.76 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.991 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.69 27.94 3.96 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 111.909 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.19 136.7 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -109.69 138.01 46.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.755 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.17 137.08 52.87 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.8 mt -117.85 136.91 53.13 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.904 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -128.93 137.17 51.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.676 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 40.8 t -123.48 136.28 54.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.1 mtm -109.31 130.72 55.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.889 0.852 . . . . 0.0 110.034 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.37 -42.31 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.01 -1.905 . . . . 0.0 107.831 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.9 p -108.86 -11.99 14.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.141 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.22 65.17 3.7 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.678 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.745 -178.818 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.916 0.389 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.53 137.04 49.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.57 7.25 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.006 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.81 26.93 7.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.936 0.398 . . . . 0.0 111.753 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 t -132.19 136.54 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -109.65 137.69 47.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.782 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.44 137.31 51.78 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tt -111.6 136.49 50.74 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.267 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -129.89 137.69 50.53 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.257 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 54.1 t -119.62 135.95 54.59 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.58 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 37.8 mtt -109.11 130.89 55.49 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.856 0.836 . . . . 0.0 110.617 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 127.48 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.998 -1.91 . . . . 0.0 108.273 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -15.05 14.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.349 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.36 67.24 2.27 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.761 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.343 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.62 -178.995 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.94 0.4 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' GLU . . . . . 0.419 ' O ' HG22 ' A' ' 126' ' ' VAL . 31.8 mt-10 -130.47 136.8 49.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.55 -100.09 0.12 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.938 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.67 34.14 1.81 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.728 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 123' ' ' GLU . 5.2 m -133.53 137.11 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -109.38 137.45 47.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.472 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.48 137.46 50.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.96 136.46 52.61 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.027 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.15 137.69 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.488 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 46.2 t -118.56 136.59 53.77 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 1.0 OUTLIER -108.93 130.48 55.45 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.707 0.765 . . . . 0.0 109.692 178.424 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.54 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.991 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.2 p -115.35 -12.12 11.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.93 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.1 67.52 2.11 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.549 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.611 -178.872 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.956 0.408 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -130.34 137.2 49.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.51 -120.27 21.4 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.07 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.28 22.67 12.33 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.875 0.369 . . . . 0.0 111.856 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.15 136.32 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -109.76 137.4 47.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.942 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -129.68 137.25 50.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.54 ' N ' HD13 ' A' ' 128' ' ' LEU . 11.0 mp -117.33 135.87 53.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.614 0.721 . . . . 0.0 109.832 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.52 137.56 49.79 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.457 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 t -127.36 135.87 51.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.566 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -109.24 131.01 55.48 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 178.581 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.49 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.226 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 31.0 p -107.29 -10.59 15.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.408 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.36 65.57 3.47 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.725 -178.754 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.898 0.38 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -130.4 137.26 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.592 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.67 -119.35 17.88 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.092 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 20.39 13.42 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.99 136.37 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -109.89 137.67 47.35 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.827 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.7 137.29 51.53 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.77 136.23 49.42 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.381 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -130.19 137.75 50.24 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.919 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 3.2 t -121.9 135.32 54.88 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.578 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.84 131.17 55.3 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.476 0.655 . . . . 0.0 110.584 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 126.34 -38.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.424 -1.716 . . . . 0.0 108.466 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.9 p -107.73 -14.02 14.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.776 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.97 67.62 2.07 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.7 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.253 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.552 -178.744 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -130.31 136.84 49.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.77 -100.25 0.19 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.839 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.28 31.94 1.92 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.826 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.06 136.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.68 137.69 47.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.736 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LEU . . . . . 0.641 HD13 ' N ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -128.85 137.33 51.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.497 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.641 ' N ' HD13 ' A' ' 128' ' ' LEU . 7.7 tt -114.79 136.17 53.38 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.533 0.682 . . . . 0.0 109.696 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -130.47 137.71 49.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.362 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 t -122.68 136.28 54.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.558 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -108.82 131.2 55.21 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.899 0.856 . . . . 0.0 110.522 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.93 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.448 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.4 p -109.43 -10.26 14.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.704 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.16 65.64 3.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.765 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.232 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.498 -179.048 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.8 mttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.848 0.356 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.65 137.24 49.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.34 -113.46 4.87 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.225 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mmt-85 -124.09 21.37 8.93 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.89 136.58 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -109.59 137.58 47.21 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.786 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.8 mt -129.29 137.31 50.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.65 136.14 53.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.265 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -130.26 137.81 50.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.275 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.0 t -122.97 136.32 54.81 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' MET . . . . . 0.553 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.4 mpp? -108.2 131.51 54.6 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.169 0.985 . . . . 0.0 111.099 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 121.39 -44.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 112.248 -2.251 . . . . 0.0 108.377 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -15.2 22.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.964 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.49 66.43 2.84 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.942 -178.667 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.4 t . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.757 0.313 . . . . 0.0 111.453 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.418 ' N ' HG12 ' A' ' 108' ' ' VAL . 8.9 mt -65.43 -49.5 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 121.94 0.876 . . . . 0.0 111.312 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -131.27 99.5 4.87 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.783 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -33.76 15.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.262 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -96.54 34.41 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 110' ' ' CYS . 0.5 OUTLIER -116.42 -29.34 6.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.016 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.6 -114.92 4.13 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.628 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.08 81.33 20.11 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 110.527 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HB3' ' CB ' ' A' ' 133' ' ' ALA . 76.8 Cg_endo -101.15 -148.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 123.969 3.113 . . . . 0.0 111.704 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.36 152.6 50.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.2 t -126.71 132.18 51.2 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.407 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -132.78 137.38 46.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.721 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.5 tt -128.54 136.22 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.0 110.574 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.22 136.86 57.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.36 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -128.3 136.47 51.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.337 . . . . 0.0 110.484 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.39 136.76 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.67 -95.85 0.06 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.816 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 35.58 1.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.083 0.468 . . . . 0.0 111.695 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.92 136.85 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -109.59 137.47 47.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.654 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.1 tp -129.51 137.23 50.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.62 136.41 52.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.432 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -130.19 137.69 50.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.129 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 51.0 t -119.84 135.98 54.66 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.28 130.74 55.49 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.785 0.803 . . . . 0.0 110.134 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 133.57 -38.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.207 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 23.9 p -114.08 -11.44 12.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.911 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.22 66.93 2.44 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.33 137.4 54.85 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.712 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.0 mp -123.23 135.9 61.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.06 0.457 . . . . 0.0 110.641 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.33 137.06 30.0 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 178.327 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 138' ' ' ARG . 61.7 Cg_endo -93.75 134.81 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.396 2.731 . . . . 0.0 112.221 177.824 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 141' ' ' ARG . 28.4 mt -144.27 156.81 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.445 ' N ' HG22 ' A' ' 140' ' ' ILE . 28.6 ptt85 -165.8 126.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.41 -36.85 5.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 1 C--O 1.092 -7.206 1 CA-C-O 89.086 -14.769 . . . . 0.0 111.079 -179.93 . . . . . . . . 2 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.1 t . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.621 0.248 . . . . 0.0 111.631 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 110' ' ' CYS . 2.3 tt -61.37 -49.35 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.862 0.839 . . . . 0.0 111.522 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.746 ' HB3' ' HB2' ' A' ' 113' ' ' CYS . 8.1 m -159.69 119.12 2.9 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.522 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -95.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.175 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.7 43.39 1.13 Allowed 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.093 0.473 . . . . 0.0 111.035 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.746 ' HB2' ' HB3' ' A' ' 110' ' ' CYS . 0.5 OUTLIER -76.73 71.71 3.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.152 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.91 117.31 4.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.407 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 116' ' ' PRO . 6.1 tttp 52.59 63.76 8.34 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.784 0.326 . . . . 0.0 110.73 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HB3' ' CB ' ' A' ' 133' ' ' ALA . 85.6 Cg_endo -101.85 -151.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.834 3.023 . . . . 0.0 111.811 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.29 160.15 42.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.216 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.0 p -124.18 132.15 53.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.115 0.484 . . . . 0.0 111.323 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.62 137.56 47.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.729 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.01 136.15 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.931 0.396 . . . . 0.0 110.781 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.41 137.19 56.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.199 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.54 136.41 51.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 110.605 177.585 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.43 137.12 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.91 -112.92 4.81 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.939 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -126.27 27.23 6.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.28 136.67 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.56 137.76 46.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.64 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mt -128.07 137.36 52.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 tt -109.82 136.57 48.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.034 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.426 ' CG ' HG22 ' A' ' 137' ' ' ILE . 10.0 mttm -129.49 137.82 51.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.424 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.1 t -119.44 136.23 54.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.564 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.9 mmm -108.68 131.1 55.24 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.905 0.859 . . . . 0.0 110.835 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 131.12 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.964 -1.925 . . . . 0.0 108.458 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 p -110.56 -12.71 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.729 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.32 67.69 2.03 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.682 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -122.98 137.28 55.0 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.546 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.426 HG22 ' CG ' ' A' ' 130' ' ' LYS . 1.5 pt -127.95 136.01 61.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 110.654 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -130.34 137.04 29.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.42 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -94.35 135.34 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.375 2.716 . . . . 0.0 112.338 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.3 pt -147.57 149.53 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.904 0.383 . . . . 0.0 111.173 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.94 97.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.997 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.4 mtp -106.66 -174.02 2.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.837 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.4 tt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.086 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 111' ' ' ARG . 1.4 t . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.617 0.246 . . . . 0.0 111.486 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.5 mt -49.94 -49.54 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.944 0.878 . . . . 0.0 111.418 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.33 38.34 1.27 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.666 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -95.71 -30.56 13.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.832 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -96.17 29.02 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.784 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.92 109.35 20.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.06 61.82 4.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.222 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 mttt 45.09 60.85 12.71 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-O 120.765 0.317 . . . . 0.0 111.583 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' HB2' ' HB2' ' A' ' 133' ' ' ALA . 96.6 Cg_endo -80.77 -102.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.64 2.226 . . . . 0.0 112.13 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.04 146.09 51.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.533 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m -128.82 131.7 47.76 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.071 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 137.21 44.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.11 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.39 136.18 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.32 136.96 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.794 0.33 . . . . 0.0 110.393 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -128.97 136.48 50.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.675 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.47 136.82 49.38 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.01 -104.85 0.51 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.945 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.32 32.97 3.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.671 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.21 136.91 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.409 ' C ' HD12 ' A' ' 128' ' ' LEU . 8.0 m-70 -109.72 137.88 46.89 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.685 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 127' ' ' HIS . 8.6 mp -128.21 137.08 51.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.14 136.54 52.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.683 0.754 . . . . 0.0 109.798 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.642 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 49.7 t -122.13 135.63 54.82 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.6 ttm -109.61 130.7 55.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.957 0.884 . . . . 0.0 111.026 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . . . 130.34 -38.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.742 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.81 -9.33 14.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.897 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.85 65.58 3.43 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.73 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.41 137.41 54.33 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.49 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.1 pp -126.19 136.15 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 110.486 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -130.19 136.52 29.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.563 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 138' ' ' ARG . 55.1 Cg_endo -97.02 114.27 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.685 2.923 . . . . 0.0 112.365 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 26.3 mm -117.85 88.47 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.883 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -100.86 -26.21 13.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.051 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 9.1 mtt 62.43 -175.66 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.751 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 1 C--O 0.474 -39.726 1 CA-C-O 52.349 -32.262 . . . . 0.0 111.085 179.962 . . . . . . . . 2 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.749 0.309 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.2 mt -58.85 -49.41 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 121.925 0.869 . . . . 0.0 111.288 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.4 m -100.57 82.2 2.42 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -117.89 26.52 9.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.48 -44.69 2.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.89 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.08 -56.71 18.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.78 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.15 123.15 0.01 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.833 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.581 ' N ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 41.11 55.46 8.07 Favored Pre-proline 0 N--CA 1.465 0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 111.514 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 115' ' ' LYS . 87.8 Cg_endo -103.42 -150.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 123.816 3.011 . . . . 0.0 111.751 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.81 146.23 43.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.6 p -127.85 132.08 49.42 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.578 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.18 137.47 46.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.517 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.948 HG23 HD23 ' A' ' 129' ' ' LEU . 35.9 mt -128.89 136.34 60.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.959 0.409 . . . . 0.0 111.002 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.2 mm -130.09 137.06 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.992 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.89 136.21 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.995 0.426 . . . . 0.0 110.712 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.44 137.04 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.41 -106.0 0.76 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.991 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.69 27.94 3.96 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 111.909 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 141' ' ' ARG . 4.0 m -132.19 136.7 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.428 ' CD2' ' HG3' ' A' ' 141' ' ' ARG . 7.7 m-70 -109.69 138.01 46.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.755 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.17 137.08 52.87 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.948 HD23 HG23 ' A' ' 120' ' ' ILE . 9.8 mt -117.85 136.91 53.13 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.904 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -128.93 137.17 51.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.676 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 40.8 t -123.48 136.28 54.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.1 mtm -109.31 130.72 55.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.889 0.852 . . . . 0.0 110.034 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.37 -42.31 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.01 -1.905 . . . . 0.0 107.831 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.9 p -108.86 -11.99 14.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.141 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.22 65.17 3.7 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.678 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -130.21 137.21 49.94 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.745 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.0 tt -127.4 135.96 61.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.896 0.379 . . . . 0.0 110.382 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 1.8 ptt180 -130.36 137.08 30.04 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.736 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 138' ' ' ARG . 62.9 Cg_endo -95.14 145.87 1.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.488 2.792 . . . . 0.0 111.986 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.0 pt -150.27 147.39 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.962 0.41 . . . . 0.0 111.156 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.497 ' O ' HG12 ' A' ' 126' ' ' VAL . 1.4 mmp_? 62.46 67.5 0.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.904 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.412 ' HA ' HG12 ' A' ' 126' ' ' VAL . 2.9 ptp -118.57 94.09 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 1.434 ' OXT' ' CA ' ' A' ' 143' ' ' ILE . 3.9 mp . . . . . 1 C--O 0.272 -50.367 1 CA-C-O 89.583 -14.532 . . . . 0.0 111.099 -179.941 . . . . . . . . 3 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.547 HD13 ' C ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -53.01 -48.91 51.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 121.729 0.776 . . . . 0.0 111.603 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -172.43 142.93 1.34 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.539 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -46.66 -60.93 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.325 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.65 68.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.061 0.457 . . . . 0.0 110.412 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 118.42 18.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.369 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.63 -56.35 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.909 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.564 ' N ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -156.77 55.86 1.09 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.73 0.3 . . . . 0.0 110.611 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 115' ' ' LYS . 44.4 Cg_endo -97.82 -141.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.408 2.738 . . . . 0.0 111.739 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 2.5 m-20 -121.91 153.16 38.81 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.382 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.6 p -126.56 132.15 51.38 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.377 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.3 tttp -133.03 137.54 46.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.801 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.4 mt -127.85 136.09 61.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.934 0.397 . . . . 0.0 110.673 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.29 137.4 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.257 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 136.34 51.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.463 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.53 137.04 49.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.57 7.25 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.006 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.81 26.93 7.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.936 0.398 . . . . 0.0 111.753 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 t -132.19 136.54 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.42 ' HB2' HG13 ' A' ' 140' ' ' ILE . 7.4 m-70 -109.65 137.69 47.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.782 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.44 137.31 51.78 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tt -111.6 136.49 50.74 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.267 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HG2' HG22 ' A' ' 137' ' ' ILE . 8.9 mttt -129.89 137.69 50.53 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.257 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 54.1 t -119.62 135.95 54.59 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.58 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 37.8 mtt -109.11 130.89 55.49 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.856 0.836 . . . . 0.0 110.617 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 127.48 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.998 -1.91 . . . . 0.0 108.273 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -15.05 14.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.349 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.36 67.24 2.27 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.761 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.46 137.26 52.64 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.62 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 130' ' ' LYS . 2.3 pp -127.69 135.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.007 0.432 . . . . 0.0 110.803 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 50.5 mtp180 -130.31 136.93 29.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.411 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 138' ' ' ARG . 64.2 Cg_endo -95.76 137.51 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.438 2.759 . . . . 0.0 112.227 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 127' ' ' HIS . 30.4 pt -150.57 140.71 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 111.274 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -152.97 43.17 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.2 108.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 21.6 pt . . . . . 1 C--O 0.899 -17.345 1 CA-C-O 14.687 -50.197 . . . . 0.0 111.136 -179.995 . . . . . . . . 2 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.797 HG12 HD13 ' A' ' 109' ' ' ILE . 2.7 t . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.582 0.229 . . . . 0.0 111.581 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.797 HD13 HG12 ' A' ' 108' ' ' VAL . 12.4 mm -55.77 -70.22 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 122.234 1.016 . . . . 0.0 111.635 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 113' ' ' CYS . 0.0 OUTLIER -168.43 135.93 2.08 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.846 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.13 -23.66 16.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.816 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -128.94 55.05 1.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.058 0.456 . . . . 0.0 111.063 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 110' ' ' CYS . 0.5 OUTLIER -123.68 -53.22 1.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.924 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.43 61.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.533 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.92 76.28 0.54 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.955 0.407 . . . . 0.0 110.819 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.4 ' HB2' ' O ' ' A' ' 132' ' ' MET . 47.5 Cg_endo -99.77 -145.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.739 2.959 . . . . 0.0 111.484 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -129.43 152.04 49.4 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.55 132.01 54.96 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.528 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -133.25 137.5 46.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.397 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.5 HG13 HD22 ' A' ' 129' ' ' LEU . 12.1 tt -127.92 136.03 61.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.973 0.416 . . . . 0.0 110.874 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 tp -130.35 137.32 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.9 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.62 136.38 51.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.94 0.4 . . . . 0.0 110.724 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' GLU . . . . . 0.419 ' O ' HG22 ' A' ' 126' ' ' VAL . 31.8 mt-10 -130.47 136.8 49.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.55 -100.09 0.12 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.938 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.67 34.14 1.81 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.728 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 123' ' ' GLU . 5.2 m -133.53 137.11 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' HIS . . . . . 0.423 ' HB2' HG23 ' A' ' 140' ' ' ILE . 7.9 m-70 -109.38 137.45 47.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.472 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.48 137.46 50.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.5 HD22 HG13 ' A' ' 120' ' ' ILE . 1.9 mm? -112.96 136.46 52.61 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.027 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.15 137.69 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.488 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 46.2 t -118.56 136.59 53.77 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 1.0 OUTLIER -108.93 130.48 55.45 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.707 0.765 . . . . 0.0 109.692 178.424 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.54 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.991 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.2 p -115.35 -12.12 11.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.93 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.1 67.52 2.11 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.549 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.64 137.51 54.72 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.611 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.68 ' O ' HD12 ' A' ' 137' ' ' ILE . 2.7 pp -127.1 135.86 62.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.063 0.458 . . . . 0.0 110.721 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.1 mtt-85 -130.36 137.19 30.29 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.484 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -92.4 139.45 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.251 2.634 . . . . 0.0 112.233 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 127' ' ' HIS . 2.2 tt -157.63 137.56 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.182 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 146.72 49.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 63.9 mtp 60.05 178.67 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.5 tt . . . . . 0 C--O 1.189 -2.092 1 CA-C-O 61.938 -27.696 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.764 0.316 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 1.006 HG21 HG21 ' A' ' 118' ' ' THR . 9.2 mt -68.11 -70.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 121.919 0.866 . . . . 0.0 111.466 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -114.57 128.53 56.38 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.894 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.61 83.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.398 . . . . 0.0 109.998 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 66.59 61.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.162 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 133' ' ' ALA . 12.1 t -55.0 -78.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.594 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.78 -66.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.817 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.422 ' CB ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -169.46 -61.76 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.656 0.228 . . . . 0.0 111.555 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' HB2' ' O ' ' A' ' 132' ' ' MET . 37.8 Cg_exo -36.66 -99.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.142 2.561 . . . . 0.0 113.419 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 171.48 -171.0 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.348 0.522 . . . . 0.0 111.71 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' THR . . . . . 1.006 HG21 HG21 ' A' ' 109' ' ' ILE . 1.2 t -130.05 133.63 46.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.797 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -128.75 137.31 51.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.695 HG23 ' HG ' ' A' ' 129' ' ' LEU . 2.4 mt -115.2 136.63 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.588 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.7 tp -129.93 137.46 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 110.249 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.48 136.52 51.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -130.34 137.2 49.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.51 -120.27 21.4 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.07 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.28 22.67 12.33 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.875 0.369 . . . . 0.0 111.856 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.15 136.32 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -109.76 137.4 47.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.942 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -129.68 137.25 50.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.924 HD13 HD13 ' A' ' 140' ' ' ILE . 11.0 mp -117.33 135.87 53.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.614 0.721 . . . . 0.0 109.832 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.52 137.56 49.79 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.457 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 t -127.36 135.87 51.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.566 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -109.24 131.01 55.48 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 178.581 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.49 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.226 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 31.0 p -107.29 -10.59 15.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.408 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.36 65.57 3.47 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -126.52 137.28 53.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.725 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 pt -127.74 135.86 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.411 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.29 136.78 29.53 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.69 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -96.68 133.01 0.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.579 2.853 . . . . 0.0 112.165 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.924 HD13 HD13 ' A' ' 129' ' ' LEU . 4.2 mp -136.13 133.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.82 0.343 . . . . 0.0 111.078 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 65.35 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -100.56 171.39 7.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 1 C--O 1.145 -4.418 1 CA-C-O 77.1 -20.476 . . . . 0.0 111.081 -179.931 . . . . . . . . 2 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.6 t . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.748 0.309 . . . . 0.0 111.638 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.516 ' N ' HG12 ' A' ' 108' ' ' VAL . 1.9 tp -49.94 -48.6 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.723 0.773 . . . . 0.0 111.768 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.478 ' N ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER 77.26 -66.09 0.25 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.401 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 165.06 -64.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.866 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.06 29.1 3.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.852 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 110' ' ' CYS . 0.0 OUTLIER -89.38 125.78 35.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.641 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.02 34.22 0.08 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.539 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.596 ' CB ' ' HD3' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -177.99 -67.6 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 117.144 0.472 . . . . 0.0 111.775 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 115' ' ' LYS . 84.2 Cg_exo -47.48 -104.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.252 1.968 . . . . 0.0 112.807 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER 168.52 -166.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.332 0.515 . . . . 0.0 110.822 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' THR . . . . . 0.664 HG22 ' SG ' ' A' ' 131' ' ' CYS . 18.9 p -129.29 132.73 47.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.815 0.34 . . . . 0.0 110.684 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -131.3 137.45 48.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.649 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.815 HG22 ' HG ' ' A' ' 129' ' ' LEU . 1.2 pp -114.06 136.51 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.154 177.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.708 HG23 ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -130.16 137.46 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.571 178.498 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.82 136.34 52.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -130.4 137.26 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.592 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.67 -119.35 17.88 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.092 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 20.39 13.42 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 141' ' ' ARG . 7.3 p -130.99 136.37 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -109.89 137.67 47.35 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.827 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.708 ' HG ' HG23 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -128.7 137.29 51.53 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.407 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.815 ' HG ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -109.77 136.23 49.42 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.381 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -130.19 137.75 50.24 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.919 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' CYS . . . . . 0.664 ' SG ' HG22 ' A' ' 118' ' ' THR . 3.2 t -121.9 135.32 54.88 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.578 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.84 131.17 55.3 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.476 0.655 . . . . 0.0 110.584 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 126.34 -38.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.424 -1.716 . . . . 0.0 108.466 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.9 p -107.73 -14.02 14.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.776 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.97 67.62 2.07 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.7 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.53 137.51 54.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.552 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mt -126.53 135.83 62.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.35 136.81 29.57 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.413 178.403 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 138' ' ' ARG . 59.9 Cg_endo -94.97 126.99 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.476 2.784 . . . . 0.0 112.467 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.5 mt -131.15 136.74 57.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.855 0.36 . . . . 0.0 110.966 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ARG . . . . . 0.654 ' O ' HG23 ' A' ' 126' ' ' VAL . 5.0 mtt180 61.21 113.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.93 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.26 34.56 1.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.433 ' OXT' HG13 ' A' ' 143' ' ' ILE . 14.4 pt . . . . . 1 C--O 0.987 -12.723 1 CA-C-O 87.661 -15.447 . . . . 0.0 111.173 179.992 . . . . . . . . 3 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.558 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.1 t . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.722 HD12 ' N ' ' A' ' 110' ' ' CYS . 2.4 pp -52.45 -49.07 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.828 0.823 . . . . 0.0 111.906 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.722 ' N ' HD12 ' A' ' 109' ' ' ILE . 1.2 m -172.36 -170.0 0.67 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.557 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -82.07 -69.53 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.542 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -125.02 46.61 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.374 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' CYS . . . . . 0.632 ' HB2' ' CB ' ' A' ' 110' ' ' CYS . 0.1 OUTLIER -99.57 76.29 2.0 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.812 -179.435 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.41 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -47.89 -85.94 0.01 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.9 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -118.09 82.09 17.3 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.809 0.338 . . . . 0.0 110.213 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.514 ' HB3' ' CB ' ' A' ' 133' ' ' ALA . 39.0 Cg_endo -104.4 -150.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 124.004 3.136 . . . . 0.0 112.077 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.79 155.91 41.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.832 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 p -125.24 132.02 53.03 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.402 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LYS . . . . . 0.632 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -133.1 137.48 46.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.594 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 119' ' ' LYS . 23.7 mm -128.85 136.17 60.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.825 0.345 . . . . 0.0 110.633 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.27 137.18 56.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.286 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.26 136.51 51.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.661 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -130.31 136.84 49.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.77 -100.25 0.19 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.839 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.28 31.94 1.92 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.826 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.06 136.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.68 137.69 47.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.736 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LEU . . . . . 0.641 HD13 ' N ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -128.85 137.33 51.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.497 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.641 ' N ' HD13 ' A' ' 128' ' ' LEU . 7.7 tt -114.79 136.17 53.38 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.533 0.682 . . . . 0.0 109.696 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -130.47 137.71 49.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.362 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 t -122.68 136.28 54.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.558 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -108.82 131.2 55.21 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.899 0.856 . . . . 0.0 110.522 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.93 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.448 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.4 p -109.43 -10.26 14.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.704 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.16 65.64 3.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.765 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -119.67 137.1 54.11 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.498 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.8 pt -128.65 136.23 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.399 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 8.1 mtt180 -130.17 136.44 29.02 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.431 ' HA ' HD22 ' A' ' 128' ' ' LEU . 54.0 Cg_endo -98.38 132.0 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.825 3.017 . . . . 0.0 112.438 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mp -133.47 92.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.879 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -72.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.046 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.4 ptm -71.26 164.02 26.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.573 HD13 ' C ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER . . . . . 1 C--O 0.902 -17.212 1 CA-C-O 55.734 -30.651 . . . . 0.0 111.028 179.949 . . . . . . . . 4 3 . 1 . 009 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.4 t . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.54 HG23 ' N ' ' A' ' 110' ' ' CYS . 2.2 tt -53.54 -49.53 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.794 0.807 . . . . 0.0 112.051 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' CYS . . . . . 0.54 ' N ' HG23 ' A' ' 109' ' ' ILE . 46.8 t 51.32 24.94 2.3 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.532 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ARG . . . . . 0.403 ' HB2' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -103.5 -56.56 2.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.869 0.366 . . . . 0.0 110.51 179.529 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.6 8.78 35.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.042 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 2.1 p -55.71 91.8 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 116' ' ' PRO . . . -93.54 -24.39 21.32 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.453 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.59 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -55.97 -37.9 62.23 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 115' ' ' LYS . 46.9 Cg_endo -92.86 -138.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.941 2.427 . . . . 0.0 111.611 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASP . . . . . 0.419 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -139.62 150.52 45.08 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.222 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.69 131.98 48.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 110.761 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -133.22 137.75 46.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.224 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.28 136.0 58.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.388 . . . . 0.0 110.345 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 30.1 mm -130.44 137.38 56.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.446 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -126.43 136.22 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.624 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.65 137.24 49.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.34 -113.46 4.87 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.225 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mmt-85 -124.09 21.37 8.93 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.89 136.58 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -109.59 137.58 47.21 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.786 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.8 mt -129.29 137.31 50.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.65 136.14 53.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.265 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -130.26 137.81 50.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.275 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.0 t -122.97 136.32 54.81 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' MET . . . . . 0.553 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.4 mpp? -108.2 131.51 54.6 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.169 0.985 . . . . 0.0 111.099 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 121.39 -44.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 112.248 -2.251 . . . . 0.0 108.377 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -15.2 22.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.964 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.49 66.43 2.84 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.2 137.28 52.88 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.942 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.41 ' C ' HD13 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -127.13 135.88 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.076 177.045 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.29 137.01 29.89 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.719 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.747 ' O ' HD13 ' A' ' 140' ' ' ILE . 61.1 Cg_endo -94.98 134.68 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.547 2.831 . . . . 0.0 112.231 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' ILE . . . . . 0.747 HD13 ' O ' ' A' ' 139' ' ' PRO . 27.2 mm -138.54 120.7 17.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.57 107.36 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.811 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' MET . . . . . 0.851 ' O ' ' O ' ' A' ' 143' ' ' ILE . 0.5 OUTLIER 61.49 162.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ILE . . . . . 0.851 ' O ' ' O ' ' A' ' 142' ' ' MET . 2.1 pp . . . . . 1 C--O 1.117 -5.913 1 CA-C-O 62.672 -27.347 . . . . 0.0 111.128 -179.939 . . . . . . . . 3 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 tttt . . . . . 0 C--O 1.231 0.121 0 CA-C-O 120.809 0.337 . . . . 0.0 110.484 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.39 136.76 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.67 -95.85 0.06 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.816 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 35.58 1.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.083 0.468 . . . . 0.0 111.695 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.92 136.85 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -109.59 137.47 47.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.654 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.1 tp -129.51 137.23 50.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.62 136.41 52.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.432 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -130.19 137.69 50.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.129 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 51.0 t -119.84 135.98 54.66 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.28 130.74 55.49 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.785 0.803 . . . . 0.0 110.134 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 133.57 -38.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.207 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 23.9 p -114.08 -11.44 12.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.911 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.22 66.93 2.44 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.227 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.712 -178.709 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.123 0 CA-C-O 120.943 0.401 . . . . 0.0 110.605 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.43 137.12 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.91 -112.92 4.81 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.939 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -126.27 27.23 6.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.28 136.67 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.56 137.76 46.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.64 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mt -128.07 137.36 52.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 tt -109.82 136.57 48.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.034 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.0 mttm -129.49 137.82 51.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.424 178.465 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.1 t -119.44 136.23 54.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.564 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.9 mmm -108.68 131.1 55.24 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.905 0.859 . . . . 0.0 110.835 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 131.12 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.964 -1.925 . . . . 0.0 108.458 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 p -110.56 -12.71 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.729 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.32 67.69 2.03 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.682 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.251 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.546 -179.011 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 mttt . . . . . 0 C--O 1.231 0.108 0 CA-C-O 120.923 0.392 . . . . 0.0 110.675 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.47 136.82 49.38 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.01 -104.85 0.51 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.945 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.32 32.97 3.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.671 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.21 136.91 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . 0.409 ' C ' HD12 ' A' ' 128' ' ' LEU . 8.0 m-70 -109.72 137.88 46.89 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.685 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 127' ' ' HIS . 8.6 mp -128.21 137.08 51.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.14 136.54 52.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.683 0.754 . . . . 0.0 109.798 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.642 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 49.7 t -122.13 135.63 54.82 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.6 ttm -109.61 130.7 55.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.957 0.884 . . . . 0.0 111.026 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.34 -38.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.742 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.81 -9.33 14.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.897 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.85 65.58 3.43 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.73 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.285 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.49 -178.864 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.995 0.426 . . . . 0.0 110.712 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.44 137.04 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.41 -106.0 0.76 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.991 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.69 27.94 3.96 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 111.909 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 m -132.19 136.7 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.792 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.7 m-70 -109.69 138.01 46.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.755 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.17 137.08 52.87 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 9.8 mt -117.85 136.91 53.13 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.904 178.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -128.93 137.17 51.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.676 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 40.8 t -123.48 136.28 54.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.1 mtm -109.31 130.72 55.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.889 0.852 . . . . 0.0 110.034 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.37 -42.31 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.01 -1.905 . . . . 0.0 107.831 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.9 p -108.86 -11.99 14.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.141 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.22 65.17 3.7 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.678 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.465 0.315 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.745 -178.818 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.118 0 CA-C-O 120.916 0.389 . . . . 0.0 110.463 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.53 137.04 49.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.57 7.25 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.006 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.81 26.93 7.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.936 0.398 . . . . 0.0 111.753 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 t -132.19 136.54 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -109.65 137.69 47.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.782 178.417 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.44 137.31 51.78 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tt -111.6 136.49 50.74 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.267 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.9 mttt -129.89 137.69 50.53 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.257 178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 54.1 t -119.62 135.95 54.59 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.58 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 37.8 mtt -109.11 130.89 55.49 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.856 0.836 . . . . 0.0 110.617 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 127.48 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.998 -1.91 . . . . 0.0 108.273 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -15.05 14.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.349 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.36 67.24 2.27 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.761 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.343 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.62 -178.995 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.94 0.4 . . . . 0.0 110.724 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . 0.419 ' O ' HG22 ' A' ' 126' ' ' VAL . 31.8 mt-10 -130.47 136.8 49.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.55 -100.09 0.12 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.938 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.67 34.14 1.81 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.728 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 123' ' ' GLU . 5.2 m -133.53 137.11 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.9 m-70 -109.38 137.45 47.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.472 178.386 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.48 137.46 50.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 1.9 mm? -112.96 136.46 52.61 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.027 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.15 137.69 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.488 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 46.2 t -118.56 136.59 53.77 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 1.0 OUTLIER -108.93 130.48 55.45 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.707 0.765 . . . . 0.0 109.692 178.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.54 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.991 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.2 p -115.35 -12.12 11.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.93 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.1 67.52 2.11 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.549 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.464 0.262 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.611 -178.872 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.956 0.408 . . . . 0.0 110.628 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -130.34 137.2 49.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.51 -120.27 21.4 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.07 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.28 22.67 12.33 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.875 0.369 . . . . 0.0 111.856 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.15 136.32 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -109.76 137.4 47.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.942 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -129.68 137.25 50.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.54 ' N ' HD13 ' A' ' 128' ' ' LEU . 11.0 mp -117.33 135.87 53.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.614 0.721 . . . . 0.0 109.832 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.52 137.56 49.79 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.457 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 t -127.36 135.87 51.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.566 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -109.24 131.01 55.48 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 178.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.49 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.226 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 31.0 p -107.29 -10.59 15.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.408 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.36 65.57 3.47 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.284 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.725 -178.754 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.146 0 CA-C-O 120.898 0.38 . . . . 0.0 110.57 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -130.4 137.26 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.592 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.67 -119.35 17.88 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.092 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 20.39 13.42 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.3 p -130.99 136.37 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.469 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -109.89 137.67 47.35 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.827 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -128.7 137.29 51.53 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.407 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -109.77 136.23 49.42 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.381 178.066 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -130.19 137.75 50.24 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.919 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 3.2 t -121.9 135.32 54.88 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.832 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.578 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.84 131.17 55.3 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.476 0.655 . . . . 0.0 110.584 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 126.34 -38.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.424 -1.716 . . . . 0.0 108.466 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.9 p -107.73 -14.02 14.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.776 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.97 67.62 2.07 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.7 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.33 -0.253 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.552 -178.744 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.232 0.139 0 CA-C-O 120.816 0.341 . . . . 0.0 110.661 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -130.31 136.84 49.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.77 -100.25 0.19 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.839 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.28 31.94 1.92 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.826 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.06 136.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.68 137.69 47.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.736 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . 0.641 HD13 ' N ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -128.85 137.33 51.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.641 ' N ' HD13 ' A' ' 128' ' ' LEU . 7.7 tt -114.79 136.17 53.38 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.533 0.682 . . . . 0.0 109.696 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -130.47 137.71 49.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.362 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 t -122.68 136.28 54.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.558 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -108.82 131.2 55.21 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.899 0.856 . . . . 0.0 110.522 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.93 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.448 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.4 p -109.43 -10.26 14.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.704 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.16 65.64 3.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.765 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.331 -0.232 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.498 -179.048 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.8 mttt . . . . . 0 C--O 1.231 0.117 0 CA-C-O 120.848 0.356 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.65 137.24 49.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.34 -113.46 4.87 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.225 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mmt-85 -124.09 21.37 8.93 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.89 136.58 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -109.59 137.58 47.21 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.786 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.8 mt -129.29 137.31 50.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.65 136.14 53.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.265 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -130.26 137.81 50.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.275 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.0 t -122.97 136.32 54.81 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' MET . . . . . 0.553 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.4 mpp? -108.2 131.51 54.6 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.169 0.985 . . . . 0.0 111.099 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 121.39 -44.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 112.248 -2.251 . . . . 0.0 108.377 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -15.2 22.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.964 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.49 66.43 2.84 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.942 -178.667 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.4 t . . . . . 0 N--CA 1.452 -0.366 0 CA-C-O 120.757 0.313 . . . . 0.0 111.453 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.418 ' N ' HG12 ' A' ' 108' ' ' VAL . 8.9 mt -65.43 -49.5 78.01 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.525 0 CA-C-O 121.94 0.876 . . . . 0.0 111.312 -179.848 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.481 ' HB3' ' HB2' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -131.27 99.5 4.87 Favored 'General case' 0 C--N 1.299 -1.611 0 CA-C-N 113.955 -1.475 . . . . 0.0 110.783 -179.946 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -90.67 -33.76 15.68 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.262 -179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -96.54 34.41 1.65 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.916 0.389 . . . . 0.0 110.781 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.481 ' HB2' ' HB3' ' A' ' 110' ' ' CYS . 0.5 OUTLIER -116.42 -29.34 6.21 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.013 -0.539 . . . . 0.0 111.016 -179.705 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 77.6 -114.92 4.13 Favored Glycine 0 C--N 1.331 0.251 0 C-N-CA 120.767 -0.73 . . . . 0.0 112.628 179.75 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.08 81.33 20.11 Favored Pre-proline 0 C--N 1.331 -0.221 0 CA-C-O 120.782 0.325 . . . . 0.0 110.527 179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.451 ' HB3' ' CB ' ' A' ' 133' ' ' ALA . 76.8 Cg_endo -101.15 -148.23 0.02 OUTLIER 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 123.969 3.113 . . . . 0.0 111.704 -179.414 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -131.36 152.6 50.46 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 179.177 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.2 t -126.71 132.18 51.2 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.396 -0.521 . . . . 0.0 111.407 179.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -132.78 137.38 46.8 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.47 -0.786 . . . . 0.0 109.721 179.028 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.5 tt -128.54 136.22 60.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-O 120.896 0.379 . . . . 0.0 110.574 177.928 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.6 pp -130.22 136.86 57.76 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.36 178.052 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 21.9 tttt -128.3 136.47 51.03 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.809 0.337 . . . . 0.0 110.484 177.712 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -130.39 136.76 49.4 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 177.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.67 -95.85 0.06 OUTLIER Glycine 0 CA--C 1.527 0.808 0 C-N-CA 119.965 -1.112 . . . . 0.0 112.816 178.506 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.37 35.58 1.08 Allowed 'General case' 0 N--CA 1.469 0.487 0 CA-C-O 121.083 0.468 . . . . 0.0 111.695 -179.541 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.6 t -133.92 136.85 53.28 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.938 0 N-CA-C 108.547 -0.908 . . . . 0.0 108.547 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.8 m-70 -109.59 137.47 47.37 Favored 'General case' 0 C--N 1.314 -0.972 0 CA-C-N 115.12 -0.946 . . . . 0.0 110.654 178.421 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 13.1 tp -129.51 137.23 50.68 Favored 'General case' 0 N--CA 1.442 -0.833 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.634 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 44.0 tp -116.62 136.41 52.99 Favored 'General case' 0 C--N 1.315 -0.933 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.432 177.891 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.9 tttp -130.19 137.69 50.21 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.908 -1.042 . . . . 0.0 109.129 178.234 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 51.0 t -119.84 135.98 54.66 Favored 'General case' 0 C--N 1.311 -1.068 0 N-CA-C 107.645 -1.243 . . . . 0.0 107.645 177.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.28 130.74 55.49 Favored 'General case' 0 N--CA 1.44 -0.957 0 CA-C-O 121.785 0.803 . . . . 0.0 110.134 178.672 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 133.57 -38.35 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 113.045 -1.889 . . . . 0.0 108.207 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 23.9 p -114.08 -11.44 12.7 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.482 -1.236 . . . . 0.0 109.911 178.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.22 66.93 2.44 Favored Glycine 0 C--N 1.337 0.599 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.33 137.4 54.85 Favored 'General case' 0 C--N 1.331 -0.227 0 C-N-CA 120.547 -0.461 . . . . 0.0 111.712 -178.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.419 ' N ' HD12 ' A' ' 137' ' ' ILE . 4.0 mp -123.23 135.9 61.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.06 0.457 . . . . 0.0 110.641 177.136 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.416 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.33 137.06 30.0 Favored Pre-proline 0 C--O 1.235 0.295 0 CA-C-N 115.849 -0.614 . . . . 0.0 110.512 178.327 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.416 ' HD3' ' HA ' ' A' ' 138' ' ' ARG . 61.7 Cg_endo -93.75 134.81 0.97 Allowed 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 123.396 2.731 . . . . 0.0 112.221 177.824 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.445 HG22 ' N ' ' A' ' 141' ' ' ARG . 28.4 mt -144.27 156.81 15.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-O 120.827 0.346 . . . . 0.0 111.125 179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.445 ' N ' HG22 ' A' ' 140' ' ' ILE . 28.6 ptt85 -165.8 126.47 1.82 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.877 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.41 -36.85 5.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.84 179.957 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 7.5 tp . . . . . 1 C--O 1.092 -7.206 1 CA-C-O 89.086 -14.769 . . . . 0.0 111.079 -179.93 . . . . . . . . 2 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.473 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.1 t . . . . . 0 N--CA 1.451 -0.411 0 CA-C-O 120.621 0.248 . . . . 0.0 111.631 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.543 HG23 ' N ' ' A' ' 110' ' ' CYS . 2.3 tt -61.37 -49.35 84.88 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.437 0 CA-C-O 121.862 0.839 . . . . 0.0 111.522 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.746 ' HB3' ' HB2' ' A' ' 113' ' ' CYS . 8.1 m -159.69 119.12 2.9 Favored 'General case' 0 C--N 1.3 -1.557 0 CA-C-N 114.092 -1.413 . . . . 0.0 110.522 -179.95 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.67 -95.99 0.0 OUTLIER 'General case' 0 CA--C 1.535 0.368 0 CA-C-N 116.163 -0.471 . . . . 0.0 112.175 -178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -105.7 43.39 1.13 Allowed 'General case' 0 N--CA 1.461 0.098 0 CA-C-O 121.093 0.473 . . . . 0.0 111.035 -179.284 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.746 ' HB2' ' HB3' ' A' ' 110' ' ' CYS . 0.5 OUTLIER -76.73 71.71 3.32 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.703 -0.68 . . . . 0.0 111.152 -179.843 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -84.91 117.31 4.47 Favored Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.692 -0.766 . . . . 0.0 112.407 179.889 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' N ' ' HD3' ' A' ' 116' ' ' PRO . 6.1 tttp 52.59 63.76 8.34 Favored Pre-proline 0 C--N 1.33 -0.248 0 CA-C-O 120.784 0.326 . . . . 0.0 110.73 -179.703 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.501 ' HB3' ' CB ' ' A' ' 133' ' ' ALA . 85.6 Cg_endo -101.85 -151.61 0.02 OUTLIER 'Trans proline' 0 N--CA 1.446 -1.311 0 C-N-CA 123.834 3.023 . . . . 0.0 111.811 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.29 160.15 42.84 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.216 179.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 43.0 p -124.18 132.15 53.59 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 121.115 0.484 . . . . 0.0 111.323 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.62 137.56 47.07 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.613 -0.721 . . . . 0.0 109.729 179.19 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.4 pp -128.01 136.15 60.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-O 120.931 0.396 . . . . 0.0 110.781 177.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 1.2 pp -130.41 137.19 56.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.199 178.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.54 136.41 51.69 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.943 0.401 . . . . 0.0 110.605 177.585 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -130.43 137.12 49.66 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.464 -0.569 . . . . 0.0 109.464 178.09 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.91 -112.92 4.81 Favored Glycine 0 CA--C 1.523 0.575 0 C-N-CA 120.196 -1.002 . . . . 0.0 112.939 178.176 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 5.0 ttm180 -126.27 27.23 6.27 Favored 'General case' 0 N--CA 1.466 0.349 0 CA-C-O 120.971 0.415 . . . . 0.0 111.678 -179.483 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 40.7 t -132.28 136.67 56.0 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.914 0 N-CA-C 108.767 -0.827 . . . . 0.0 108.767 179.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.56 137.76 46.92 Favored 'General case' 0 C--N 1.313 -0.993 0 CA-C-N 114.956 -1.02 . . . . 0.0 110.64 178.481 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 11.1 mt -128.07 137.36 52.12 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.52 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 7.9 tt -109.82 136.57 48.92 Favored 'General case' 0 C--N 1.312 -1.024 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.034 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.426 ' CG ' HG22 ' A' ' 137' ' ' ILE . 10.0 mttm -129.49 137.82 51.04 Favored 'General case' 0 C--N 1.304 -1.402 0 CA-C-N 114.797 -1.092 . . . . 0.0 109.424 178.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.1 t -119.44 136.23 54.39 Favored 'General case' 0 C--N 1.311 -1.102 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 176.828 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.564 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.9 mmm -108.68 131.1 55.24 Favored 'General case' 0 N--CA 1.442 -0.874 0 CA-C-O 121.905 0.859 . . . . 0.0 110.835 179.202 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.564 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 131.12 -39.32 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 112.964 -1.925 . . . . 0.0 108.458 179.773 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.2 p -110.56 -12.71 14.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 114.652 -1.158 . . . . 0.0 109.729 178.328 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.32 67.69 2.03 Favored Glycine 0 C--N 1.338 0.645 0 C-N-CA 120.938 -0.649 . . . . 0.0 111.682 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -122.98 137.28 55.0 Favored 'General case' 0 N--CA 1.464 0.251 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.546 -179.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.426 HG22 ' CG ' ' A' ' 130' ' ' LYS . 1.5 pt -127.95 136.01 61.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.997 0.427 . . . . 0.0 110.654 177.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 23.8 ttp180 -130.34 137.04 29.96 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.42 178.201 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -94.35 135.34 0.86 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.375 2.716 . . . . 0.0 112.338 177.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.3 pt -147.57 149.53 15.39 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.904 0.383 . . . . 0.0 111.173 179.873 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 62.94 97.32 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.997 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 16.4 mtp -106.66 -174.02 2.43 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.837 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.4 tt . . . . . 0 C--O 1.249 1.044 0 CA-C-O 118.227 -0.892 . . . . 0.0 111.086 -179.988 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.425 ' HA ' ' HB2' ' A' ' 111' ' ' ARG . 1.4 t . . . . . 0 N--CA 1.452 -0.356 0 CA-C-O 120.617 0.246 . . . . 0.0 111.486 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.5 mt -49.94 -49.54 21.0 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.448 0 CA-C-O 121.944 0.878 . . . . 0.0 111.418 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 49.7 t -97.33 38.34 1.27 Allowed 'General case' 0 C--N 1.301 -1.515 0 CA-C-N 113.982 -1.463 . . . . 0.0 110.666 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.425 ' HB2' ' HA ' ' A' ' 108' ' ' VAL . 0.0 OUTLIER -95.71 -30.56 13.67 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.832 179.981 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 1.4 mt-10 -96.17 29.02 2.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.167 -0.469 . . . . 0.0 110.784 179.761 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -88.92 109.35 20.16 Favored 'General case' 0 N--CA 1.452 -0.36 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.575 -179.881 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -85.06 61.82 4.61 Favored Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.774 -0.727 . . . . 0.0 113.222 -179.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 14.7 mttt 45.09 60.85 12.71 Favored Pre-proline 0 N--CA 1.464 0.228 0 CA-C-O 120.765 0.317 . . . . 0.0 111.583 179.52 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.547 ' HB2' ' HB2' ' A' ' 133' ' ' ALA . 96.6 Cg_endo -80.77 -102.07 0.0 OUTLIER 'Trans proline' 0 N--CA 1.46 -0.445 0 C-N-CA 122.64 2.226 . . . . 0.0 112.13 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -129.04 146.09 51.1 Favored 'General case' 0 CA--C 1.519 -0.222 0 C-N-CA 120.264 -0.575 . . . . 0.0 110.533 179.584 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 1.3 m -128.82 131.7 47.76 Favored 'General case' 0 C--N 1.329 -0.308 0 C-N-CA 120.363 -0.535 . . . . 0.0 111.071 179.418 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.1 137.21 44.44 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.842 -0.617 . . . . 0.0 110.11 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -129.39 136.18 59.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 177.704 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.6 OUTLIER -130.32 136.96 57.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-O 120.794 0.33 . . . . 0.0 110.393 178.231 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 12.3 mttt -128.97 136.48 50.4 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.675 177.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.47 136.82 49.38 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.163 -0.68 . . . . 0.0 109.163 177.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.01 -104.85 0.51 Allowed Glycine 0 CA--C 1.526 0.76 0 C-N-CA 120.045 -1.074 . . . . 0.0 112.945 178.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -135.32 32.97 3.08 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.091 0.472 . . . . 0.0 111.671 -179.494 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 41.0 t -133.21 136.91 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.887 0 N-CA-C 108.598 -0.89 . . . . 0.0 108.598 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.409 ' C ' HD12 ' A' ' 128' ' ' LEU . 8.0 m-70 -109.72 137.88 46.89 Favored 'General case' 0 C--N 1.313 -1.001 0 CA-C-N 115.107 -0.951 . . . . 0.0 110.685 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.409 HD12 ' C ' ' A' ' 127' ' ' HIS . 8.6 mp -128.21 137.08 51.88 Favored 'General case' 0 N--CA 1.442 -0.861 0 N-CA-C 108.217 -1.031 . . . . 0.0 108.217 177.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.14 136.54 52.82 Favored 'General case' 0 C--N 1.314 -0.943 0 CA-C-O 121.683 0.754 . . . . 0.0 109.798 178.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -130.0 137.77 50.45 Favored 'General case' 0 C--N 1.305 -1.355 0 CA-C-N 114.543 -1.208 . . . . 0.0 108.642 178.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 49.7 t -122.13 135.63 54.82 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.748 -1.204 . . . . 0.0 107.748 177.176 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.543 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 14.6 ttm -109.61 130.7 55.49 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 121.957 0.884 . . . . 0.0 111.026 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.547 ' HB2' ' HB2' ' A' ' 116' ' ' PRO . . . 130.34 -38.73 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 112.571 -2.104 . . . . 0.0 108.742 179.794 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 21.6 p -110.81 -9.33 14.48 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 114.814 -1.084 . . . . 0.0 109.897 178.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.85 65.58 3.43 Favored Glycine 0 C--N 1.338 0.646 0 C-N-CA 120.904 -0.665 . . . . 0.0 111.73 -179.467 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -120.41 137.41 54.33 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.49 -178.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.1 pp -126.19 136.15 61.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.969 0.414 . . . . 0.0 110.486 177.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.424 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 0.1 OUTLIER -130.19 136.52 29.13 Favored Pre-proline 0 C--N 1.328 -0.334 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.563 178.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 138' ' ' ARG . 55.1 Cg_endo -97.02 114.27 0.12 Allowed 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 123.685 2.923 . . . . 0.0 112.365 178.091 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 26.3 mm -117.85 88.47 1.21 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.883 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 38.2 ttm180 -100.86 -26.21 13.84 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.11 -0.495 . . . . 0.0 111.051 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 9.1 mtt 62.43 -175.66 0.14 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.751 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 3.8 mt . . . . . 1 C--O 0.474 -39.726 1 CA-C-O 52.349 -32.262 . . . . 0.0 111.085 179.962 . . . . . . . . 2 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.1 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.749 0.309 . . . . 0.0 111.375 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 5.2 mt -58.85 -49.41 83.06 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.518 0 CA-C-O 121.925 0.869 . . . . 0.0 111.288 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . . . . . . . . . 1.4 m -100.57 82.2 2.42 Favored 'General case' 0 C--N 1.3 -1.558 0 CA-C-N 113.884 -1.507 . . . . 0.0 110.938 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 3.8 ttp180 -117.89 26.52 9.62 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.213 -0.448 . . . . 0.0 111.152 -179.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -123.48 -44.69 2.11 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.89 179.855 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 1.0 OUTLIER -60.08 -56.71 18.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.78 179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 63.15 123.15 0.01 OUTLIER Glycine 0 CA--C 1.518 0.23 0 C-N-CA 120.78 -0.724 . . . . 0.0 112.833 179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.581 ' N ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER 41.11 55.46 8.07 Favored Pre-proline 0 N--CA 1.465 0.291 0 CA-C-O 120.748 0.309 . . . . 0.0 111.514 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.581 ' HD3' ' N ' ' A' ' 115' ' ' LYS . 87.8 Cg_endo -103.42 -150.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 123.816 3.011 . . . . 0.0 111.751 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -117.81 146.23 43.99 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.893 -0.41 . . . . 0.0 109.893 179.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 66.6 p -127.85 132.08 49.42 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.24 -0.584 . . . . 0.0 111.578 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -133.18 137.47 46.2 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.517 179.206 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.948 HG23 HD23 ' A' ' 129' ' ' LEU . 35.9 mt -128.89 136.34 60.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.959 0.409 . . . . 0.0 111.002 178.109 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 32.2 mm -130.09 137.06 57.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.992 177.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.89 136.21 51.07 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.995 0.426 . . . . 0.0 110.712 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -130.44 137.04 49.62 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.349 -0.611 . . . . 0.0 109.349 178.03 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.41 -106.0 0.76 Allowed Glycine 0 CA--C 1.526 0.745 0 C-N-CA 120.136 -1.03 . . . . 0.0 112.991 178.088 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -133.69 27.94 3.96 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-O 121.002 0.43 . . . . 0.0 111.909 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.497 HG12 ' O ' ' A' ' 141' ' ' ARG . 4.0 m -132.19 136.7 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.832 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 179.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.428 ' CD2' ' HG3' ' A' ' 141' ' ' ARG . 7.7 m-70 -109.69 138.01 46.67 Favored 'General case' 0 C--N 1.312 -1.042 0 CA-C-N 114.927 -1.033 . . . . 0.0 110.755 178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 1.2 mt -127.17 137.08 52.87 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 177.191 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.948 HD23 HG23 ' A' ' 120' ' ' ILE . 9.8 mt -117.85 136.91 53.13 Favored 'General case' 0 C--N 1.313 -1.008 0 CA-C-N 115.473 -0.785 . . . . 0.0 109.904 178.324 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.4 mmmt -128.93 137.17 51.24 Favored 'General case' 0 C--N 1.307 -1.265 0 CA-C-N 114.707 -1.133 . . . . 0.0 108.676 177.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 40.8 t -123.48 136.28 54.5 Favored 'General case' 0 N--CA 1.435 -1.209 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 177.903 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.549 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.1 mtm -109.31 130.72 55.49 Favored 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 121.889 0.852 . . . . 0.0 110.034 178.457 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.549 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.37 -42.31 0.01 OUTLIER 'General case' 0 C--N 1.32 -0.685 0 CA-C-N 113.01 -1.905 . . . . 0.0 107.831 -179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 20.9 p -108.86 -11.99 14.95 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 114.325 -1.307 . . . . 0.0 109.141 177.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.22 65.17 3.7 Favored Glycine 0 C--N 1.34 0.779 0 CA-C-N 115.835 -0.621 . . . . 0.0 111.678 -179.651 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -130.21 137.21 49.94 Favored 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 120.153 -0.619 . . . . 0.0 111.745 -178.818 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 15.0 tt -127.4 135.96 61.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.896 0.379 . . . . 0.0 110.382 177.271 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.447 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 1.8 ptt180 -130.36 137.08 30.04 Favored Pre-proline 0 C--O 1.236 0.363 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.736 178.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.447 ' HD3' ' HA ' ' A' ' 138' ' ' ARG . 62.9 Cg_endo -95.14 145.87 1.47 Allowed 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.488 2.792 . . . . 0.0 111.986 177.676 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 4.0 pt -150.27 147.39 16.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 120.962 0.41 . . . . 0.0 111.156 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.497 ' O ' HG12 ' A' ' 126' ' ' VAL . 1.4 mmp_? 62.46 67.5 0.71 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.904 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.412 ' HA ' HG12 ' A' ' 126' ' ' VAL . 2.9 ptp -118.57 94.09 4.34 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.9 179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 1.434 ' OXT' ' CA ' ' A' ' 143' ' ' ILE . 3.9 mp . . . . . 1 C--O 0.272 -50.367 1 CA-C-O 89.583 -14.532 . . . . 0.0 111.099 -179.941 . . . . . . . . 3 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.538 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.452 -0.36 0 N-CA-C 111.819 0.303 . . . . 0.0 111.819 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.547 HD13 ' C ' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -53.01 -48.91 51.6 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-O 121.729 0.776 . . . . 0.0 111.603 -179.575 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.51 ' N ' HG23 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -172.43 142.93 1.34 Allowed 'General case' 0 C--N 1.3 -1.577 0 CA-C-N 114.242 -1.345 . . . . 0.0 110.539 179.899 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -46.66 -60.93 2.07 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.386 -0.37 . . . . 0.0 111.325 -179.73 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -154.65 68.61 0.72 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.061 0.457 . . . . 0.0 110.412 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -75.72 118.42 18.52 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.872 -0.604 . . . . 0.0 111.369 -179.541 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -140.63 -56.35 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.979 -0.629 . . . . 0.0 111.909 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.564 ' N ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -156.77 55.86 1.09 Allowed Pre-proline 0 C--N 1.329 -0.321 0 CA-C-O 120.73 0.3 . . . . 0.0 110.611 179.459 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.564 ' HD3' ' N ' ' A' ' 115' ' ' LYS . 44.4 Cg_endo -97.82 -141.81 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 123.408 2.738 . . . . 0.0 111.739 -179.696 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.406 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 2.5 m-20 -121.91 153.16 38.81 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 121.018 -0.273 . . . . 0.0 110.382 179.507 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 60.6 p -126.56 132.15 51.38 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.457 -0.497 . . . . 0.0 111.377 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 27.3 tttp -133.03 137.54 46.49 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.539 -0.755 . . . . 0.0 109.801 179.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 4.4 mt -127.85 136.09 61.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-O 120.934 0.397 . . . . 0.0 110.673 177.632 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -130.29 137.4 56.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.257 178.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.64 136.34 51.48 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.463 177.475 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -130.53 137.04 49.52 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.347 -0.612 . . . . 0.0 109.347 178.194 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.37 -115.57 7.25 Favored Glycine 0 CA--C 1.525 0.661 0 C-N-CA 120.191 -1.004 . . . . 0.0 113.006 178.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -122.81 26.93 7.97 Favored 'General case' 0 N--CA 1.467 0.41 0 CA-C-O 120.936 0.398 . . . . 0.0 111.753 -179.338 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 35.7 t -132.19 136.54 56.32 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.883 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.42 ' HB2' HG13 ' A' ' 140' ' ' ILE . 7.4 m-70 -109.65 137.69 47.11 Favored 'General case' 0 C--N 1.313 -0.995 0 CA-C-N 115.126 -0.943 . . . . 0.0 110.782 178.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -128.44 137.31 51.78 Favored 'General case' 0 N--CA 1.443 -0.82 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 177.515 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 2.9 tt -111.6 136.49 50.74 Favored 'General case' 0 C--N 1.314 -0.964 0 CA-C-N 115.285 -0.871 . . . . 0.0 109.267 177.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.425 ' HG2' HG22 ' A' ' 137' ' ' ILE . 8.9 mttt -129.89 137.69 50.53 Favored 'General case' 0 C--N 1.305 -1.365 0 CA-C-N 114.779 -1.1 . . . . 0.0 109.257 178.452 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 54.1 t -119.62 135.95 54.59 Favored 'General case' 0 C--N 1.31 -1.112 0 N-CA-C 107.558 -1.275 . . . . 0.0 107.558 177.017 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.58 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 37.8 mtt -109.11 130.89 55.49 Favored 'General case' 0 N--CA 1.44 -0.926 0 CA-C-O 121.856 0.836 . . . . 0.0 110.617 178.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.58 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 127.48 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.591 0 CA-C-N 112.998 -1.91 . . . . 0.0 108.273 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -107.2 -15.05 14.75 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 114.507 -1.224 . . . . 0.0 109.349 178.31 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.36 67.24 2.27 Favored Glycine 0 C--N 1.336 0.56 0 CA-C-N 115.927 -0.579 . . . . 0.0 111.761 -179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.46 137.26 52.64 Favored 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 120.275 -0.57 . . . . 0.0 111.62 -178.995 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.425 HG22 ' HG2' ' A' ' 130' ' ' LYS . 2.3 pp -127.69 135.96 61.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 121.007 0.432 . . . . 0.0 110.803 177.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.402 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 50.5 mtp180 -130.31 136.93 29.76 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-N 115.857 -0.61 . . . . 0.0 110.411 178.1 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.402 ' HD3' ' HA ' ' A' ' 138' ' ' ARG . 64.2 Cg_endo -95.76 137.51 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 123.438 2.759 . . . . 0.0 112.227 177.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.42 HG13 ' HB2' ' A' ' 127' ' ' HIS . 30.4 pt -150.57 140.71 16.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.829 0.347 . . . . 0.0 111.274 179.767 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 1.8 ttt180 -152.97 43.17 0.62 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.132 -0.485 . . . . 0.0 110.849 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 62.2 108.51 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.191 -0.459 . . . . 0.0 110.914 -179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 21.6 pt . . . . . 1 C--O 0.899 -17.345 1 CA-C-O 14.687 -50.197 . . . . 0.0 111.136 -179.995 . . . . . . . . 2 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.797 HG12 HD13 ' A' ' 109' ' ' ILE . 2.7 t . . . . . 0 N--CA 1.45 -0.434 0 CA-C-O 120.582 0.229 . . . . 0.0 111.581 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.797 HD13 HG12 ' A' ' 108' ' ' VAL . 12.4 mm -55.77 -70.22 0.12 Allowed 'Isoleucine or valine' 0 CA--C 1.508 -0.651 0 CA-C-O 122.234 1.016 . . . . 0.0 111.635 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.63 ' HB3' ' HB2' ' A' ' 113' ' ' CYS . 0.0 OUTLIER -168.43 135.93 2.08 Favored 'General case' 0 C--N 1.295 -1.802 0 CA-C-N 113.428 -1.714 . . . . 0.0 110.846 -179.499 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -97.13 -23.66 16.11 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.293 -0.412 . . . . 0.0 111.816 -179.39 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -128.94 55.05 1.75 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 121.058 0.456 . . . . 0.0 111.063 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.63 ' HB2' ' HB3' ' A' ' 110' ' ' CYS . 0.5 OUTLIER -123.68 -53.22 1.78 Allowed 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.924 -179.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . 98.43 61.15 0.89 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.764 -0.732 . . . . 0.0 112.533 179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER 53.92 76.28 0.54 Allowed Pre-proline 0 C--N 1.329 -0.298 0 CA-C-O 120.955 0.407 . . . . 0.0 110.819 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.4 ' HB2' ' O ' ' A' ' 132' ' ' MET . 47.5 Cg_endo -99.77 -145.93 0.02 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 123.739 2.959 . . . . 0.0 111.484 -179.727 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -129.43 152.04 49.4 Favored 'General case' 0 C--N 1.328 -0.347 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 179.056 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.55 132.01 54.96 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.285 -0.566 . . . . 0.0 111.528 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 18.0 mtpp -133.25 137.5 46.1 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.386 -0.824 . . . . 0.0 109.397 179.207 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.5 HG13 HD22 ' A' ' 129' ' ' LEU . 12.1 tt -127.92 136.03 61.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.973 0.416 . . . . 0.0 110.874 177.911 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 4.3 tp -130.35 137.32 56.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.9 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -127.62 136.38 51.56 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 120.94 0.4 . . . . 0.0 110.724 177.648 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . 0.419 ' O ' HG22 ' A' ' 126' ' ' VAL . 31.8 mt-10 -130.47 136.8 49.36 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 177.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 57.55 -100.09 0.12 Allowed Glycine 0 CA--C 1.526 0.768 0 C-N-CA 119.948 -1.12 . . . . 0.0 112.938 178.413 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 16.2 mmt180 -140.67 34.14 1.81 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.064 0.459 . . . . 0.0 111.728 -179.493 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.419 HG22 ' O ' ' A' ' 123' ' ' GLU . 5.2 m -133.53 137.11 53.54 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.886 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 -179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . 0.423 ' HB2' HG23 ' A' ' 140' ' ' ILE . 7.9 m-70 -109.38 137.45 47.22 Favored 'General case' 0 C--N 1.314 -0.95 0 CA-C-N 115.069 -0.969 . . . . 0.0 110.472 178.386 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -129.48 137.46 50.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 N-CA-C 108.773 -0.825 . . . . 0.0 108.773 177.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.5 HD22 HG13 ' A' ' 120' ' ' ILE . 1.9 mm? -112.96 136.46 52.61 Favored 'General case' 0 C--N 1.313 -1.019 0 CA-C-N 115.474 -0.785 . . . . 0.0 109.027 177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -130.15 137.69 50.25 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-N 114.943 -1.026 . . . . 0.0 109.488 178.5 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 46.2 t -118.56 136.59 53.77 Favored 'General case' 0 C--N 1.312 -1.06 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 176.92 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.537 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 1.0 OUTLIER -108.93 130.48 55.45 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 121.707 0.765 . . . . 0.0 109.692 178.424 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.537 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 135.54 -38.45 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 113.061 -1.881 . . . . 0.0 107.991 -179.565 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.2 p -115.35 -12.12 11.8 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 114.46 -1.246 . . . . 0.0 109.93 178.295 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 60.1 67.52 2.11 Favored Glycine 0 C--N 1.338 0.643 0 C-N-CA 120.903 -0.665 . . . . 0.0 111.549 -179.364 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.64 137.51 54.72 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 120.549 -0.46 . . . . 0.0 111.611 -178.872 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.68 ' O ' HD12 ' A' ' 137' ' ' ILE . 2.7 pp -127.1 135.86 62.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 121.063 0.458 . . . . 0.0 110.721 177.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 12.1 mtt-85 -130.36 137.19 30.29 Favored Pre-proline 0 C--O 1.235 0.32 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.484 178.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 65.7 Cg_endo -92.4 139.45 1.94 Allowed 'Trans proline' 0 N--CA 1.456 -0.705 0 C-N-CA 123.251 2.634 . . . . 0.0 112.233 177.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.423 HG23 ' HB2' ' A' ' 127' ' ' HIS . 2.2 tt -157.63 137.56 4.02 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 120.814 0.34 . . . . 0.0 111.182 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.81 146.72 49.57 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.861 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 63.9 mtp 60.05 178.67 0.09 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.85 -179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 18.5 tt . . . . . 0 C--O 1.189 -2.092 1 CA-C-O 61.938 -27.696 . . . . 0.0 111.145 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.4 t . . . . . 0 N--CA 1.452 -0.37 0 CA-C-O 120.764 0.316 . . . . 0.0 111.46 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 1.006 HG21 HG21 ' A' ' 118' ' ' THR . 9.2 mt -68.11 -70.22 0.22 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.507 0 CA-C-O 121.919 0.866 . . . . 0.0 111.466 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.462 ' HB3' ' HB2' ' A' ' 113' ' ' CYS . 0.8 OUTLIER -114.57 128.53 56.38 Favored 'General case' 0 C--N 1.299 -1.614 0 CA-C-N 114.119 -1.4 . . . . 0.0 110.894 -179.889 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.61 83.24 0.1 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.398 . . . . 0.0 109.998 179.32 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 66.59 61.96 0.54 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.162 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.553 ' SG ' ' HB3' ' A' ' 133' ' ' ALA . 12.1 t -55.0 -78.39 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.93 -0.577 . . . . 0.0 111.594 -179.408 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.78 -66.88 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.541 -0.838 . . . . 0.0 112.817 -179.777 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.422 ' CB ' ' HD3' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -169.46 -61.76 0.0 OUTLIER Pre-proline 0 CA--C 1.531 0.227 0 CA-C-N 116.656 0.228 . . . . 0.0 111.555 -179.808 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.47 ' HB2' ' O ' ' A' ' 132' ' ' MET . 37.8 Cg_exo -36.66 -99.62 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.7 0 C-N-CA 123.142 2.561 . . . . 0.0 113.419 -179.413 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 171.48 -171.0 0.03 OUTLIER 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 118.348 0.522 . . . . 0.0 111.71 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 1.006 HG21 HG21 ' A' ' 109' ' ' ILE . 1.2 t -130.05 133.63 46.85 Favored 'General case' 0 C--N 1.332 -0.181 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.797 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 11.4 mtpt -128.75 137.31 51.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.534 178.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.695 HG23 ' HG ' ' A' ' 129' ' ' LEU . 2.4 mt -115.2 136.63 51.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.464 -0.335 . . . . 0.0 110.588 177.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.7 tp -129.93 137.46 56.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.94 0.4 . . . . 0.0 110.249 178.157 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -127.48 136.52 51.89 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.109 -0.496 . . . . 0.0 110.628 177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 2.9 mt-10 -130.34 137.2 49.81 Favored 'General case' 0 C--N 1.33 -0.24 0 N-CA-C 109.513 -0.551 . . . . 0.0 109.513 178.091 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.51 -120.27 21.4 Favored Glycine 0 CA--C 1.524 0.626 0 C-N-CA 120.282 -0.961 . . . . 0.0 113.07 178.036 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -117.28 22.67 12.33 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 120.875 0.369 . . . . 0.0 111.856 -179.355 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.4 p -131.15 136.32 58.03 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.895 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 179.495 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.3 m-70 -109.76 137.4 47.62 Favored 'General case' 0 C--N 1.312 -1.053 0 CA-C-N 115.12 -0.945 . . . . 0.0 110.942 178.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.54 HD13 ' N ' ' A' ' 129' ' ' LEU . 0.4 OUTLIER -129.68 137.25 50.52 Favored 'General case' 0 N--CA 1.442 -0.852 0 N-CA-C 107.959 -1.126 . . . . 0.0 107.959 177.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.924 HD13 HD13 ' A' ' 140' ' ' ILE . 11.0 mp -117.33 135.87 53.53 Favored 'General case' 0 C--N 1.312 -1.026 0 CA-C-O 121.614 0.721 . . . . 0.0 109.832 177.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -130.52 137.56 49.79 Favored 'General case' 0 C--N 1.305 -1.343 0 CA-C-N 114.641 -1.163 . . . . 0.0 108.457 178.003 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 19.3 t -127.36 135.87 51.1 Favored 'General case' 0 C--N 1.308 -1.196 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 177.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.566 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.9 OUTLIER -109.24 131.01 55.48 Favored 'General case' 0 N--CA 1.441 -0.897 0 CA-C-N 115.511 -0.768 . . . . 0.0 110.104 178.581 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.49 -42.11 0.01 OUTLIER 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 113.405 -1.725 . . . . 0.0 108.226 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 31.0 p -107.29 -10.59 15.77 Favored 'General case' 0 N--CA 1.449 -0.496 0 CA-C-N 114.505 -1.225 . . . . 0.0 109.408 177.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 56.36 65.57 3.47 Favored Glycine 0 C--N 1.338 0.686 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.692 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -126.52 137.28 53.35 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.309 -0.556 . . . . 0.0 111.725 -178.754 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 1.3 pt -127.74 135.86 61.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.323 -0.398 . . . . 0.0 110.411 177.19 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.29 136.78 29.53 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 116.081 -0.509 . . . . 0.0 110.69 178.303 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -96.68 133.01 0.4 Allowed 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 123.579 2.853 . . . . 0.0 112.165 177.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.924 HD13 HD13 ' A' ' 129' ' ' LEU . 4.2 mp -136.13 133.07 50.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-O 120.82 0.343 . . . . 0.0 111.078 179.846 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.09 65.35 0.9 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.898 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -100.56 171.39 7.76 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.119 -0.492 . . . . 0.0 110.874 179.923 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . . . . . . . . . 24.4 mm . . . . . 1 C--O 1.145 -4.418 1 CA-C-O 77.1 -20.476 . . . . 0.0 111.081 -179.931 . . . . . . . . 2 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.516 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.6 t . . . . . 0 N--CA 1.453 -0.282 0 CA-C-O 120.748 0.309 . . . . 0.0 111.638 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.516 ' N ' HG12 ' A' ' 108' ' ' VAL . 1.9 tp -49.94 -48.6 22.44 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.451 0 CA-C-O 121.723 0.773 . . . . 0.0 111.768 -179.545 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.478 ' N ' HG23 ' A' ' 109' ' ' ILE . 0.0 OUTLIER 77.26 -66.09 0.25 Allowed 'General case' 0 C--N 1.303 -1.452 0 CA-C-N 114.255 -1.339 . . . . 0.0 110.401 -179.602 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 9.2 mtt-85 165.06 -64.27 0.0 OUTLIER 'General case' 0 C--O 1.232 0.158 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.866 179.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 -134.06 29.1 3.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.689 -0.687 . . . . 0.0 109.852 178.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.436 ' HB2' ' HB3' ' A' ' 110' ' ' CYS . 0.0 OUTLIER -89.38 125.78 35.28 Favored 'General case' 0 N--CA 1.449 -0.477 0 CA-C-N 115.453 -0.794 . . . . 0.0 110.641 -179.588 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -178.02 34.22 0.08 OUTLIER Glycine 0 C--N 1.331 0.274 0 C-N-CA 119.935 -1.126 . . . . 0.0 113.539 -179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.596 ' CB ' ' HD3' ' A' ' 116' ' ' PRO . 0.1 OUTLIER -177.99 -67.6 0.0 OUTLIER Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 117.144 0.472 . . . . 0.0 111.775 179.242 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.596 ' HD3' ' CB ' ' A' ' 115' ' ' LYS . 84.2 Cg_exo -47.48 -104.23 0.0 OUTLIER 'Trans proline' 0 CA--C 1.538 0.711 0 C-N-CA 122.252 1.968 . . . . 0.0 112.807 -179.609 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.403 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 0.2 OUTLIER 168.52 -166.37 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.431 0 CA-C-N 118.332 0.515 . . . . 0.0 110.822 -179.675 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . 0.664 HG22 ' SG ' ' A' ' 131' ' ' CYS . 18.9 p -129.29 132.73 47.21 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.815 0.34 . . . . 0.0 110.684 179.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 2.2 mttp -131.3 137.45 48.82 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.649 179.353 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.815 HG22 ' HG ' ' A' ' 129' ' ' LEU . 1.2 pp -114.06 136.51 50.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.154 177.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.708 HG23 ' HG ' ' A' ' 128' ' ' LEU . 0.5 OUTLIER -130.16 137.46 56.35 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.274 0 CA-C-O 120.845 0.355 . . . . 0.0 110.571 178.498 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -126.82 136.34 52.24 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.114 -0.494 . . . . 0.0 110.57 177.137 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 9.7 mt-10 -130.4 137.26 49.77 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.028 -0.533 . . . . 0.0 109.592 178.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.67 -119.35 17.88 Favored Glycine 0 CA--C 1.523 0.539 0 C-N-CA 120.342 -0.932 . . . . 0.0 113.092 177.881 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -117.77 20.39 13.42 Favored 'General case' 0 N--CA 1.465 0.281 0 N-CA-C 111.908 0.336 . . . . 0.0 111.908 -179.335 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . 0.654 HG23 ' O ' ' A' ' 141' ' ' ARG . 7.3 p -130.99 136.37 58.14 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.888 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 7.4 m-70 -109.89 137.67 47.35 Favored 'General case' 0 C--N 1.313 -1.005 0 CA-C-N 115.062 -0.972 . . . . 0.0 110.827 178.576 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.708 ' HG ' HG23 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -128.7 137.29 51.53 Favored 'General case' 0 N--CA 1.442 -0.865 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 177.407 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.815 ' HG ' HG22 ' A' ' 120' ' ' ILE . 0.3 OUTLIER -109.77 136.23 49.42 Favored 'General case' 0 N--CA 1.438 -1.042 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.381 178.066 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 4.2 tmtm? -130.19 137.75 50.24 Favored 'General case' 0 C--N 1.302 -1.463 0 CA-C-N 114.6 -1.182 . . . . 0.0 108.919 178.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . 0.664 ' SG ' HG22 ' A' ' 118' ' ' THR . 3.2 t -121.9 135.32 54.88 Favored 'General case' 0 C--N 1.308 -1.232 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 176.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.578 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -109.84 131.17 55.3 Favored 'General case' 0 N--CA 1.442 -0.851 0 CA-C-O 121.476 0.655 . . . . 0.0 110.584 179.306 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.578 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 126.34 -38.83 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 113.424 -1.716 . . . . 0.0 108.466 179.663 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 27.9 p -107.73 -14.02 14.89 Favored 'General case' 0 N--CA 1.449 -0.518 0 CA-C-N 114.478 -1.237 . . . . 0.0 109.776 178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 59.97 67.62 2.07 Favored Glycine 0 C--N 1.336 0.545 0 C-N-CA 120.932 -0.651 . . . . 0.0 111.7 -179.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -123.53 137.51 54.75 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.559 -0.457 . . . . 0.0 111.552 -178.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 39.4 mt -126.53 135.83 62.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 120.961 0.41 . . . . 0.0 110.673 177.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.449 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 0.0 OUTLIER -130.35 136.81 29.57 Favored Pre-proline 0 C--O 1.235 0.324 0 CA-C-N 115.988 -0.551 . . . . 0.0 110.413 178.403 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.449 ' HD3' ' HA ' ' A' ' 138' ' ' ARG . 59.9 Cg_endo -94.97 126.99 0.42 Allowed 'Trans proline' 0 N--CA 1.454 -0.82 0 C-N-CA 123.476 2.784 . . . . 0.0 112.467 178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 11.5 mt -131.15 136.74 57.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.855 0.36 . . . . 0.0 110.966 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . 0.654 ' O ' HG23 ' A' ' 126' ' ' VAL . 5.0 mtt180 61.21 113.17 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.93 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -141.26 34.56 1.69 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.2 -0.454 . . . . 0.0 110.86 -179.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.433 ' OXT' HG13 ' A' ' 143' ' ' ILE . 14.4 pt . . . . . 1 C--O 0.987 -12.723 1 CA-C-O 87.661 -15.447 . . . . 0.0 111.173 179.992 . . . . . . . . 3 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.558 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.1 t . . . . . 0 N--CA 1.451 -0.376 0 N-CA-C 111.837 0.31 . . . . 0.0 111.837 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.722 HD12 ' N ' ' A' ' 110' ' ' CYS . 2.4 pp -52.45 -49.07 44.95 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.429 0 CA-C-O 121.828 0.823 . . . . 0.0 111.906 -179.499 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.722 ' N ' HD12 ' A' ' 109' ' ' ILE . 1.2 m -172.36 -170.0 0.67 Allowed 'General case' 0 C--N 1.299 -1.599 0 CA-C-N 114.139 -1.391 . . . . 0.0 110.557 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . . . . . . . . . 6.3 mtt180 -82.07 -69.53 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.841 0.353 . . . . 0.0 110.542 179.517 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 17.4 mt-10 -125.02 46.61 2.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.374 179.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . 0.632 ' HB2' ' CB ' ' A' ' 110' ' ' CYS . 0.1 OUTLIER -99.57 76.29 2.0 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.731 -0.668 . . . . 0.0 110.812 -179.435 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.41 ' O ' ' HD3' ' A' ' 116' ' ' PRO . . . -47.89 -85.94 0.01 OUTLIER Glycine 0 C--N 1.332 0.359 0 C-N-CA 120.983 -0.627 . . . . 0.0 112.9 -179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.5 tttp -118.09 82.09 17.3 Favored Pre-proline 0 C--N 1.329 -0.305 0 CA-C-O 120.809 0.338 . . . . 0.0 110.213 179.631 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.514 ' HB3' ' CB ' ' A' ' 133' ' ' ALA . 39.0 Cg_endo -104.4 -150.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.335 0 C-N-CA 124.004 3.136 . . . . 0.0 112.077 -178.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -148.79 155.91 41.61 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.103 -0.499 . . . . 0.0 109.832 179.169 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 9.1 p -125.24 132.02 53.03 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.367 -0.533 . . . . 0.0 111.402 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . 0.632 ' O ' HD13 ' A' ' 120' ' ' ILE . 0.9 OUTLIER -133.1 137.48 46.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.575 -0.739 . . . . 0.0 109.594 179.237 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.632 HD13 ' O ' ' A' ' 119' ' ' LYS . 23.7 mm -128.85 136.17 60.44 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.825 0.345 . . . . 0.0 110.633 177.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -130.27 137.18 56.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.277 -0.419 . . . . 0.0 110.286 178.067 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -128.26 136.51 51.13 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.661 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 11.3 tt0 -130.31 136.84 49.56 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 178.011 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 59.77 -100.25 0.19 Allowed Glycine 0 CA--C 1.524 0.648 0 C-N-CA 120.071 -1.062 . . . . 0.0 112.839 178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -140.28 31.94 1.92 Allowed 'General case' 0 N--CA 1.467 0.401 0 CA-C-O 121.002 0.43 . . . . 0.0 111.826 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 4.0 m -133.06 136.6 55.12 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.805 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.1 m-70 -109.68 137.69 47.12 Favored 'General case' 0 C--N 1.314 -0.977 0 CA-C-N 114.919 -1.037 . . . . 0.0 110.736 178.486 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . 0.641 HD13 ' N ' ' A' ' 129' ' ' LEU . 0.3 OUTLIER -128.85 137.33 51.42 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 177.497 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.641 ' N ' HD13 ' A' ' 128' ' ' LEU . 7.7 tt -114.79 136.17 53.38 Favored 'General case' 0 C--N 1.314 -0.965 0 CA-C-O 121.533 0.682 . . . . 0.0 109.696 178.095 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 1.2 ttmt -130.47 137.71 49.92 Favored 'General case' 0 C--N 1.306 -1.298 0 CA-C-N 114.818 -1.083 . . . . 0.0 109.362 178.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 48.6 t -122.68 136.28 54.83 Favored 'General case' 0 C--N 1.312 -1.043 0 N-CA-C 107.617 -1.253 . . . . 0.0 107.617 176.76 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.558 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 0.0 OUTLIER -108.82 131.2 55.21 Favored 'General case' 0 N--CA 1.441 -0.888 0 CA-C-O 121.899 0.856 . . . . 0.0 110.522 178.911 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.558 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 130.93 -40.66 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 113.031 -1.895 . . . . 0.0 108.448 179.816 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 29.4 p -109.43 -10.26 14.9 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 114.648 -1.16 . . . . 0.0 109.704 178.305 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 58.16 65.64 3.37 Favored Glycine 0 C--N 1.337 0.601 0 C-N-CA 120.952 -0.642 . . . . 0.0 111.765 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -119.67 137.1 54.11 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.51 -0.476 . . . . 0.0 111.498 -179.048 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 17.8 pt -128.65 136.23 60.41 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.399 177.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . 0.421 ' HA ' ' HD3' ' A' ' 139' ' ' PRO . 8.1 mtt180 -130.17 136.44 29.02 Favored Pre-proline 0 C--O 1.236 0.382 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.48 178.219 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.431 ' HA ' HD22 ' A' ' 128' ' ' LEU . 54.0 Cg_endo -98.38 132.0 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 123.825 3.017 . . . . 0.0 112.438 178.215 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . . . . . . . . . 3.8 mp -133.47 92.18 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.879 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.99 -72.76 0.28 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 0.0 111.046 -179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . . . . . . . . . 3.4 ptm -71.26 164.02 26.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.862 179.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.573 HD13 ' C ' ' A' ' 143' ' ' ILE . 0.0 OUTLIER . . . . . 1 C--O 0.902 -17.212 1 CA-C-O 55.734 -30.651 . . . . 0.0 111.028 179.949 . . . . . . . . 4 3 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.529 HG12 ' N ' ' A' ' 109' ' ' ILE . 1.4 t . . . . . 0 N--CA 1.452 -0.369 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.54 HG23 ' N ' ' A' ' 110' ' ' CYS . 2.2 tt -53.54 -49.53 54.76 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.374 0 CA-C-O 121.794 0.807 . . . . 0.0 112.051 -179.181 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' CYS . . . . . 0.54 ' N ' HG23 ' A' ' 109' ' ' ILE . 46.8 t 51.32 24.94 2.3 Favored 'General case' 0 C--N 1.302 -1.494 0 CA-C-N 114.351 -1.295 . . . . 0.0 111.532 179.854 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ARG . . . . . 0.403 ' HB2' ' CD1' ' A' ' 109' ' ' ILE . 0.0 OUTLIER -103.5 -56.56 2.19 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.869 0.366 . . . . 0.0 110.51 179.529 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -91.6 8.78 35.04 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.131 -0.486 . . . . 0.0 111.042 179.544 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' CYS . . . . . . . . . . . . . 2.1 p -55.71 91.8 0.01 OUTLIER 'General case' 0 C--N 1.333 -0.122 0 CA-C-O 120.869 0.366 . . . . 0.0 110.873 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.408 ' C ' ' HD2' ' A' ' 116' ' ' PRO . . . -93.54 -24.39 21.32 Favored Glycine 0 C--N 1.331 0.282 0 C-N-CA 120.895 -0.669 . . . . 0.0 112.453 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.59 ' N ' ' CD ' ' A' ' 116' ' ' PRO . 0.0 OUTLIER -55.97 -37.9 62.23 Favored Pre-proline 0 C--N 1.33 -0.26 0 N-CA-C 111.534 0.198 . . . . 0.0 111.534 179.678 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' PRO . . . . . 0.59 ' CD ' ' N ' ' A' ' 115' ' ' LYS . 46.9 Cg_endo -92.86 -138.27 0.02 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.782 0 C-N-CA 122.941 2.427 . . . . 0.0 111.611 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASP . . . . . 0.419 ' H ' ' HB2' ' A' ' 116' ' ' PRO . 0.4 OUTLIER -139.62 150.52 45.08 Favored 'General case' 0 N--CA 1.462 0.165 0 C-N-CA 120.14 -0.624 . . . . 0.0 111.222 179.878 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.69 131.98 48.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.135 0.493 . . . . 0.0 110.761 179.32 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LYS . . . . . . . . . . . . . 1.7 mttm -133.22 137.75 46.25 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.224 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -120.28 136.0 58.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.916 0.388 . . . . 0.0 110.345 177.42 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 30.1 mm -130.44 137.38 56.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.446 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' LYS . . . . . . . . . . . . . 38.8 mttt -126.43 136.22 52.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.848 0.356 . . . . 0.0 110.624 177.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -130.65 137.24 49.49 Favored 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.592 -0.522 . . . . 0.0 109.592 178.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' GLY . . . . . . . . . . . . . . . 58.34 -113.46 4.87 Favored Glycine 0 CA--C 1.524 0.597 0 C-N-CA 120.242 -0.98 . . . . 0.0 113.225 177.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' ARG . . . . . . . . . . . . . 38.8 mmt-85 -124.09 21.37 8.93 Favored 'General case' 0 N--CA 1.467 0.392 0 N-CA-C 112.069 0.396 . . . . 0.0 112.069 -179.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' VAL . . . . . . . . . . . . . 7.1 p -130.89 136.58 57.81 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.841 0 N-CA-C 108.563 -0.903 . . . . 0.0 108.563 179.37 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' HIS . . . . . . . . . . . . . 8.0 m-70 -109.59 137.58 47.21 Favored 'General case' 0 C--N 1.313 -1.018 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.786 178.651 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LEU . . . . . . . . . . . . . 62.8 mt -129.29 137.31 50.96 Favored 'General case' 0 N--CA 1.443 -0.799 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 8.8 tt -113.65 136.14 53.16 Favored 'General case' 0 C--N 1.312 -1.039 0 CA-C-N 115.643 -0.708 . . . . 0.0 109.265 177.724 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 8.4 mmmm -130.26 137.81 50.2 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.275 178.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' CYS . . . . . . . . . . . . . 44.0 t -122.97 136.32 54.81 Favored 'General case' 0 C--N 1.313 -1.02 0 N-CA-C 107.541 -1.281 . . . . 0.0 107.541 176.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' MET . . . . . 0.553 ' O ' ' CB ' ' A' ' 133' ' ' ALA . 2.4 mpp? -108.2 131.51 54.6 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 122.169 0.985 . . . . 0.0 111.099 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.553 ' CB ' ' O ' ' A' ' 132' ' ' MET . . . 121.39 -44.35 0.01 OUTLIER 'General case' 0 CA--C 1.515 -0.371 0 CA-C-N 112.248 -2.251 . . . . 0.0 108.377 179.729 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -95.59 -15.2 22.96 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 114.931 -1.031 . . . . 0.0 108.964 177.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' GLY . . . . . . . . . . . . . . . 57.49 66.43 2.84 Favored Glycine 0 C--N 1.338 0.687 0 N-CA-C 111.524 -0.63 . . . . 0.0 111.524 -179.743 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ALA . . . . . . . . . . . . . . . -127.2 137.28 52.88 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.31 -0.556 . . . . 0.0 111.942 -178.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.41 ' C ' HD13 ' A' ' 137' ' ' ILE . 0.0 OUTLIER -127.13 135.88 62.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.076 177.045 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -130.29 137.01 29.89 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.719 178.517 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.747 ' O ' HD13 ' A' ' 140' ' ' ILE . 61.1 Cg_endo -94.98 134.68 0.66 Allowed 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.547 2.831 . . . . 0.0 112.231 177.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' ILE . . . . . 0.747 HD13 ' O ' ' A' ' 139' ' ' PRO . 27.2 mm -138.54 120.7 17.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 CA-C-O 120.862 0.363 . . . . 0.0 111.106 179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.57 107.36 0.67 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.811 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' MET . . . . . 0.851 ' O ' ' O ' ' A' ' 143' ' ' ILE . 0.5 OUTLIER 61.49 162.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.822 -179.917 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ILE . . . . . 0.851 ' O ' ' O ' ' A' ' 142' ' ' MET . 2.1 pp . . . . . 1 C--O 1.117 -5.913 1 CA-C-O 62.672 -27.347 . . . . 0.0 111.128 -179.939 . . . . . . . . 3 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_